Major coronary heart disease event excluding revascularizations

I9_CHD_NOREV

intermediate coronary syndrome: Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Main diagnosis only: side diagnoses are not checked. Registry filters: Hospital discharge: ICD-10 — I20.0, I21, I22 Hospital discharge: ICD-9 — 410\|4110 Hospital discharge: ICD-8 — 410\|4110 Cause of death: ICD-10 — I21, I22, I23, I24, I25, I46, R96, R98 Cause of death: ICD-9 — 41[0-4]\|798 Cause of death: ICD-8 — 41[0-4]\|798 Cause of death: excluded ICD-9 — 7980A 2 out of 7 registries used, show all original rules.	49336
4. Check minimum number of events None	49336
5. Include endpoints K.I9_MI	49446
6. Filter based on genotype QC (FinnGen only)	49446

Control definitions (FinnGen only)

Control exclude: I9_CHD

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_CHD_NOREV
CONTROL_EXCLUDE	I9_CHD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K.I9_MI
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I200\|I21\|I22
HD_ICD_9	410\|4110
HD_ICD_8	410\|4110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY	YES
COD_ICD_10	I2[1-5]\|I46\|R96\|R98
COD_ICD_9	41[0-4]\|798
COD_ICD_8	41[0-4]\|798
COD_ICD_10_EXCL
COD_ICD_9_EXCL	7980A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Major coronary heart disease event excluding revascularizations based on the number of shared cases.

Similar with more cases:

Ischaemic heart disease, wide definition

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	49446	15059	34387
Unadjusted period prevalence (%)	12.11	5.13	15.16
Median age at first event (years)	67.80	70.32	66.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15406: Matched controls
133004

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

13464.9

323.0

3625

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

323.0

8490

40902

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

20.4

323.0

3066

1600

AN1

Coronary angiography

20.5

323.0

5415

3429

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

323.0

10344

60814

I25.2

ICD-10 Finland

Old myocardial infarction

196.2

323.0

3541

202

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

323.0

4981

21982

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

34.4

323.0

2120

613

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.7

323.0

4476

8958

AN4

Balloon angioplasty and drug eluding stent

+∞

323.0

1918

Single vessel balloon catheter extension

+∞

323.0

664

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

323.0

1125

AA1

Conventional CABG

+∞

323.0

480

WX872

NOMESCO Finland

Intensive care

6.6

323.0

1504

2160

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

323.0

4684

21572

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3153.6

323.0

4002

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

20.4

323.0

1801

857

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

120.1

323.0

459

Angiography of the heart and coronary arteries

13.0

323.0

1661

1227

280

Kela drug reimbursment

Clopidogrel

151.1

323.0

557

R06.0

ICD-10 Finland

Dyspnoea

2.2

323.0

4225

19120

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

323.0

4115

17822

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

40.6

323.0

3984

1132

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

11.0

323.0

827

682

C10AA07

ATC

rosuvastatin; oral

2.6

323.0

5422

23086

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

1515

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

15.7

323.0

9018

10949

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.7

323.0

4252

16514

I20.09

ICD-10 Finland

Unstable angina

570.8

323.0

4394

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

12.4

323.0

1941

1523

AN2

Balloon angioplasty, including several vessels

+∞

323.0

1078

C10AX09

ATC

ezetimibe; oral

6.7

323.0

4245

7143

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

8.3

323.0

928

1015

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

342.9

323.0

1251

C07AB02

ATC

metoprolol; systemic

2.8

323.0

3698

13496

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

27.7

323.0

543

175

C03CA01

ATC

furosemide; systemic

3.3

323.0

5030

16946

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.7

323.0

4656

8030

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

2953

K76

ICPC

Ischaemic heart dis without angina

22.3

323.0

828

337

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.9

323.0

4797

11317

C07AB07

ATC

bisoprolol; oral

6.5

323.0

11472

40996

A10BA02

ATC

metformin; oral

2.1

323.0

4799

23312

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

323.0

337

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.3

323.0

5643

15830

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

442

C10AA05

ATC

atorvastatin; oral

5.1

323.0

10050

35671

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

323.0

580

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

31.8

323.0

11156

10128

I50.9

ICD-10 Finland

Heart failure, unspecified

5.0

323.0

2315

4508

I20.01

ICD-10 Finland

Unstable angina

1208.5

323.0

1850

XF400

NOMESCO Finland

ECG with 12 standard connections

3.5

323.0

3678

10950

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.5

323.0

1081

1809

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

9.8

323.0

1118

1057

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.7

323.0

2358

6187

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

31.8

323.0

2520

813

R07.4

ICD-10 Finland

Chest pain, unspecified

4.7

323.0

7502

22214

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

10648

69813

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

5.1

323.0

1648

3036

C01DA14

ATC

isosorbide mononitrate; oral

14.5

323.0

4527

3707

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

550

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

49.6

323.0

463

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

6899.0

323.0

769

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

88.9

323.0

1858

205

AN3

Balloon angioplasty and metallic stent

+∞

323.0

1298

I20.99

ICD-10 Finland

Angina pectoris, unspecified

9.3

323.0

1968

2055

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

63.1

323.0

9202

3057

I50.0

ICD-10 Finland

Congestive heart failure

6.5

323.0

1179

1679

I50.1

ICD-10 Finland

Left ventricular failure

7.2

323.0

956

1205

I20.90

ICD-10 Finland

Angina pectoris, unspecified

9.6

323.0

939

890

XF402

NOMESCO Finland

ECG with work load test

3.6

323.0

2834

7791

B01AC24

ATC

ticagrelor; oral

726.0

323.0

3419

I25

ICD-10 Finland

Chronic ischaemic heart disease

23.1

323.0

1770

742

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

4084.2

323.0

1328

C08CA01

ATC

amlodipine; oral

2.1

323.0

6394

33092

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

29.4

323.0

648

198

I25.1

ICD-10 Finland

Atherosclerotic heart disease

35.5

323.0

9693

6057

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

2400

B01AC04

ATC

clopidogrel; oral

13.8

323.0

6201

6179

C10AA01

ATC

simvastatin; oral

3.0

323.0

8804

40817

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

6860.8

323.0

765

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

323.0

406

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

7.8

323.0

911

1060

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

319.7

323.0

364

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2406.6

323.0

820

I20.00

ICD-10 Finland

Unstable angina

982.6

323.0

1811

C03DA01

ATC

spironolactone; oral

3.2

323.0

2000

6008

C09AA05

ATC

ramipril; oral

5.1

323.0

6738

17713

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2038.7

323.0

1142

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

323.0

2674

8888

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

1113

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

11409.6

323.0

1227

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.3

319.2

1868

5391

Coronary artery bypass surgery

+∞

318.1

322

A10AE04

ATC

insulin glargine; parenteral

3.2

317.7

1917

5656

WX892

NOMESCO Finland

Monitored bed care

3.5

316.0

1656

4389

R07.3

ICD-10 Finland

Other chest pain

3.1

309.5

1992

6144

A11

ICPC

Chest pain NOS

3.4

308.4

1676

4566

B01AA03

ATC

warfarin; systemic

2.5

306.8

2848

10994

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.9

300.7

1373

3234

205

Kela drug reimbursment

Chronic hypertension

2.1

300.0

4506

21880

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.8

298.8

1411

3422

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

287.3

291

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.3

276.9

3127

13267

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

276.4

2029

6787

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

276.4

2906

11900

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

268.0

1469

4008

T90

ICPC

Diabetes non-insulin dependent

2.1

264.2

4096

19945

201

Kela drug reimbursment

Chronic cardiac insufficiency

5.5

258.3

837

1381

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

255.8

3542

16408

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

774.8

255.2

265

K74

ICPC

Ischaemic heart dis with angina

17.9

240.0

398

197

Z50.0

ICD-10 Finland

Cardiac rehabilitation

21.8

239.6

372

151

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

239.2

4555

23839

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.8

236.4

1756

5878

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

224.1

234.5

255

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.7

233.9

645

863

I20.0

ICD-10 Finland

Unstable angina

33.9

231.3

319

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.5

230.6

903

1827

FL1AC

NOMESCO Finland

Left cardioangiography

11.8

228.7

450

338

K84

ICPC

Heart disease other

6.7

228.2

630

844

R4110

NOMESCO Finland

Physiotherapy

1.9

227.5

4485

23677

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

21.3

227.2

355

147

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

45.4

226.6

294

AP1

Catheterization of the left side of the heart

10.9

223.7

458

373

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

13.5

222.6

412

270

AA1AD

NOMESCO Finland

CT of head and brain

1.9

216.3

3769

18947

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.4

214.9

1180

3202

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

1843.1

213.7

219

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

56.3

210.4

263

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.6

206.4

1023

2557

207

Kela drug reimbursment

Chronic arrhythmias

2.3

205.4

2188

8884

C10AA04

ATC

fluvastatin; oral

2.7

205.2

1552

5228

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

33.1

203.5

282

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

201.2

1181

3362

SPAT1262

SPAT

Handing over of treatment supplies

2.0

199.9

3061

14567

N02AX02

ATC

tramadol; systemic, rectal

1.7

198.7

6782

42182

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

31.5

196.9

276

A10AE05

ATC

insulin detemir; parenteral

3.4

195.8

1047

2777

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

195.8

1513

5154

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.8

193.6

706

1323

C10AA03

ATC

pravastatin; oral

2.9

193.2

1331

4222

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

12.0

192.2

374

274

I20.91

ICD-10 Finland

Angina pectoris, unspecified

21.3

192.1

300

124

A10AA02

ATC

5.1

188.2

649

1144

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

185.6

3069

14991

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

185.4

188

B01AC22

ATC

prasugrel; oral

79.9

184.2

219

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

183.8

2159

9139

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.1

180.8

765

1661

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

36.9

180.6

244

XF404

NOMESCO Finland

Ambulatory ECG

2.5

177.5

1638

6150

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.9

171.8

770

1760

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

11.2

171.2

345

272

SPAT1097

SPAT

Recording of ECG

2.0

170.6

2474

11433

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

168.6

171

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

167.6

170

A10AA01

ATC

5.0

165.7

572

1008

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

159.9

1288

4473

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

158.4

4411

25392

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

49.1

158.1

202

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

1450.0

156.5

161

I20

ICD-10 Finland

Angina pectoris

8.6

152.4

354

363

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

151.7

1837

7832

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.5

151.0

1314

4758

N02BE01

ATC

paracetamol; systemic, rectal

1.8

146.6

12981

100075

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.5

146.0

759

1960

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

6.5

145.1

405

549

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.7

143.5

528

996

A10BK03

ATC

empagliflozin; oral

2.4

143.3

1386

5301

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

17.2

142.6

239

122

C09AA02

ATC

enalapril; systemic

1.8

138.4

2887

15096

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.0

137.4

606

1362

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

419.6

137.3

145

R53

ICD-10 Finland

Malaise and fatigue

1.8

137.2

2610

13228

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

137.0

139

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

608.6

134.1

140

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

133.8

1271

4808

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

132.5

851

2558

H3603, E103

ICD-10 Finland

8.7

129.7

298

300

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

24.9

128.6

191

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

128.5

756

2138

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

128.4

1692

7444

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.0

128.4

260

207

I20.10

ICD-10 Finland

Angina angiospastic

27.9

128.4

185

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

127.1

4087

24175

Catheterization and pressure measurement of the left side of the heart

9.9

126.7

271

240

A10BB12

ATC

glimepiride; oral

2.7

125.2

976

3308

ANB

Coronary thrombectomy

+∞

124.1

126

C08DB01

ATC

diltiazem; oral

3.2

123.7

719

2015

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

122.6

2453

12589

Multi-vessel balloon catheter extension

+∞

121.2

123

R07.2

ICD-10 Finland

Precordial pain

4.4

118.2

463

930

FXZ00

NOMESCO Finland

Off-pump cardiac operation

35.7

117.9

160

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.1

117.2

499

1085

I47.2

ICD-10 Finland

Ventricular tachycardia

5.2

116.5

390

663

AA2

Off pump CABG sternotomy

+∞

116.2

118

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

8.8

115.2

263

262

A10BH01

ATC

sitagliptin; oral

2.1

115.1

1522

6687

R02

ICPC

Shortness of breath/dyspnoea

2.0

113.9

1715

7936

TK800

NOMESCO Finland

Hemodialysis

4.2

113.5

465

975

M04AA01

ATC

allopurinol; systemic

2.0

112.3

1699

7875

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

111.9

587

1523

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

15.3

111.8

195

111

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

109.6

1264

5228

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.7

109.4

339

526

SPAT1254

SPAT

Administration of medicine

1.9

109.0

1834

8832

K01

ICPC

Heart pain

6.9

107.9

289

370

H02AB06

ATC

prednisolone; systemic

1.5

105.2

6576

44826

N03AX16

ATC

pregabalin; oral

1.6

104.7

3572

21249

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

56.5

104.5

130

111

Conventional CABG

+∞

104.4

106

I21

ICD-10 Finland

Acute myocardial infarction

104.4

104.3

120

SPAT1263

SPAT

Sampling

1.5

103.0

5698

37817

R03BB04

ATC

tiotropium bromide; inhalant

2.1

102.4

1362

5985

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.9

102.4

458

1041

T89

ICPC

Diabetes insulin dependent

3.0

102.3

634

1855

C08CA13

ATC

lercanidipine; oral

1.8

100.5

2002

10196

I50

ICD-10 Finland

Heart failure

4.6

100.0

375

721

ANE

Coronary internal ultrasound (IVUS)

139.1

99.9

112

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.9

99.7

243

270

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

99.4

409

861

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

99.4

793

2716

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

99.3

2380

12833

C01AA05

ATC

digoxin; systemic

2.7

99.2

758

2532

I20.9

ICD-10 Finland

Angina pectoris, unspecified

8.0

98.5

238

261

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

98.5

1845

9201

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.2

95.6

548

1517

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

95.6

4621

29677

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

95.3

827

2967

R42

ICD-10 Finland

Dizziness and giddiness

1.6

95.3

2890

16618

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.2

95.3

387

805

B01AF02

ATC

apixaban; oral

2.0

95.1

1326

5930

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

94.8

1457

6764

C08CA02

ATC

felodipine; oral

2.0

94.8

1299

5770

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.9

94.6

638

1973

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

94.5

567

1621

J01FF01

ATC

clindamycin; systemic

1.5

94.1

3946

24545

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

93.6

1866

9491

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

+∞

93.6

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

12.6

93.4

177

123

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

92.5

919

3532

N02AA05

ATC

oxycodone; systemic

1.8

92.1

1919

9895

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

33.0

90.6

125

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

+∞

90.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

89.0

1394

6512

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.4

88.9

463

1193

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

88.6

412

968

K75

ICPC

Acute myocardial infarction

59.1

88.3

109

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

26.5

88.0

128

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

87.1

1513

7331

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

6.0

87.1

255

369

R03AC02

ATC

salbutamol; inhalant

1.4

86.6

7173

50880

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

+∞

85.7

C01BD01

ATC

amiodarone; systemic

3.3

85.3

472

1274

C09CA01

ATC

losartan; oral

1.5

85.0

3615

22455

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

85.0

5429

36657

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

265.3

84.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

84.4

1954

10384

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

84.0

1496

7306

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

754.3

83.8

SPAT1301

SPAT

No procedures

1.5

83.4

4121

26416

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

8.8

83.3

189

187

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.2

83.3

337

699

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.7

83.2

636

2122

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.5

83.2

209

244

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

83.1

5273

35516

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

82.8

6721

47349

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

82.7

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.1

82.2

344

736

R55

ICD-10 Finland

Syncope and collapse

1.9

82.0

1348

6398

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

81.7

2241

12483

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

+∞

81.7

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

+∞

81.7

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

20.0

81.7

129

N03AX12

ATC

gabapentin; oral

1.6

81.3

2243

12512

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.0

81.0

515

1532

C08CA07

ATC

nisoldipine; oral

10.4

80.6

167

140

ZX120

NOMESCO Finland

Intravenous

1.9

80.6

1322

6269

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

80.0

868

3476

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.0

79.7

192

210

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

79.1

3783

24030

NHQ40

NOMESCO Finland

Amputation of toe

4.8

78.9

282

516

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.4

78.6

253

412

C02AC05

ATC

moxonidine; oral

2.4

78.6

726

2689

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

151.0

78.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

78.2

411

1067

A10BB01

ATC

glibenclamide; oral

3.7

77.5

360

846

A10BH05

ATC

linagliptin; oral

2.6

77.3

631

2187

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

71.9

75.9

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

7.6

75.5

187

214

A02BC01

ATC

omeprazole; systemic

1.5

75.2

3723

23776

SPAT1104

SPAT

Monitoring of emergency patient

2.1

74.9

961

4141

M79.6

ICD-10 Finland

Pain in limb

1.4

74.5

4893

32984

A28

ICPC

Limited function/disability NOS

1.7

74.5

1634

8518

C09DX04

ATC

valsartan and sacubitril; oral

7.4

74.4

187

219

K02

ICPC

Pressure/tightness of heart

3.3

73.9

400

1062

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

8.0

73.9

178

195

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.5

73.9

280

545

C07AG02

ATC

carvedilol; oral

2.2

73.9

837

3418

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.2

73.7

245

414

I42.8

ICD-10 Finland

Other cardiomyopathies

9.9

73.6

156

137

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.3

73.3

237

388

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

73.0

1037

4653

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4.0

72.9

313

686

S97

ICPC

Chronic ulcer skin

2.3

72.9

731

2817

R11

ICD-10 Finland

Nausea and vomiting

2.0

72.8

968

4230

A46

ICD-10 Finland

Erysipelas

1.7

72.7

1887

10327

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

72.7

3345

21013

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.1

72.4

299

633

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.4

71.6

148

124

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

71.3

775

3103

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.5

71.2

224

355

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.7

71.2

175

198

A02BC03

ATC

lansoprazole; oral

1.4

71.2

4136

27198

I51.4

ICD-10 Finland

Myocarditis, unspecified

8.8

70.7

160

158

A11CC03

ATC

alfacalcidol; systemic

3.4

70.5

369

955

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.5

70.4

266

516

M10.9

ICD-10 Finland

Gout, unspecified

2.1

70.3

834

3473

A12BA01

ATC

potassium chloride; oral

2.8

69.9

493

1566

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

69.9

516

1686

B01AC07

ATC

dipyridamole; systemic

3.5

69.7

351

881

PE1AT

NOMESCO Finland

Femoral artery PTA

5.9

69.7

207

306

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.0

69.6

434

1275

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

69.4

863

3665

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.9

69.1

302

673

K22

ICPC

Risk factor cardiovascular disease

2.2

68.9

776

3158

R51.80

ICD-10 Finland

Headache

1.7

68.7

1779

9715

K78

ICPC

Atrial fibrillation/flutter

2.1

68.4

858

3658

5315

FHL

Bypass surgery using a mammary artery

+∞

67.9

C03AA03

ATC

hydrochlorothiazide; oral

1.8

67.9

1315

6583

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

67.8

1045

4830

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.7

67.8

486

1561

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

66.8

2315

13617

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.3

66.5

367

989

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.7

66.3

201

305

N05CF01

ATC

zopiclone; oral

1.4

66.1

4328

29003

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.4

66.0

348

906

J01DB01

ATC

cefalexin; oral

1.4

65.9

11799

93127

I20.19

ICD-10 Finland

Angina angiospastic

24.8

65.7

I20.08

ICD-10 Finland

Unstable angina

301.5

65.6

H3603, E113

ICD-10 Finland

6.0

65.2

190

274

UJF32

NOMESCO Finland

Coloscopy

1.4

65.1

3555

23020

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

50.8

65.0

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.6

64.6

241

462

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

64.4

1263

6344

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.9

64.1

225

405

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

64.0

934

4227

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

10.5

64.0

131

108

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

63.7

394

1151

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

63.4

847

3702

R04.0

ICD-10 Finland

Epistaxis

2.0

63.3

894

3998

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

63.2

2052

11867

A12AA04

ATC

calcium carbonate; oral

4.1

63.0

264

567

J01MA12

ATC

levofloxacin; systemic

1.5

62.2

2403

14469

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.6

62.1

154

177

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

61.7

971

4520

G47.3

ICD-10 Finland

Sleep apnoea

1.4

61.7

3277

21073

C08CA05

ATC

nifedipine; systemic

2.1

61.7

749

3147

PD5AD

NOMESCO Finland

CT of aorta

4.2

61.6

249

517

WX890

NOMESCO Finland

Intesive care monitoring

8.3

61.5

144

151

WX720

NOMESCO Finland

Own respiration

2.4

61.5

584

2190

C09CA03

ATC

valsartan; oral

1.7

61.0

1300

6696

C09AA04

ATC

perindopril; oral

2.1

60.9

714

2956

H3601, E113

ICD-10 Finland

4.2

60.9

247

515

A06AD11

ATC

lactulose; oral

1.7

60.8

1557

8457

FXG00

NOMESCO Finland

Insertion and use of IABP

35.5

60.8

A04

ICPC

Weakness/tiredness general

1.7

60.6

1363

7135

SPAT1310

SPAT

Counselling related to known health issue

1.4

60.6

4181

28182

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

60.5

900

4102

A02BA02

ATC

ranitidine; systemic

1.5

60.5

2640

16310

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

60.4

977

4592

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

60.3

2864

18004

L28

ICPC

Limited function/disability (L)

1.6

60.1

1842

10491

C02EA02

ATC

2.6

59.8

463

1557

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

59.7

648

2588

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

59.7

3660

24147

K92

ICPC

Atherosclerosis/periph vascular dis

5.1

59.7

201

346

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.1

59.4

200

344

N06AX11

ATC

mirtazapine; oral

1.4

59.1

4229

28660

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

58.6

1527

8329

H04AA01

ATC

glucagon; nasal, parenteral

3.5

58.6

296

746

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.0

58.6

199

346

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.6

58.5

144

164

I49.5

ICD-10 Finland

Sick sinus syndrome

2.7

58.5

432

1412

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

58.3

1505

8190

A02BC05

ATC

esomeprazole; systemic

1.3

58.3

5764

41117

C10AX13

ATC

evolocumab; parenteral

17.9

58.2

315

Kela drug reimbursment

Clopidogrel

6.3

58.0

164

228

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

58.0

597

2329

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

7.4

57.8

145

170

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.6

57.7

177

273

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

57.7

1231

6340

K77

ICPC

Heart failure

4.4

57.6

220

433

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

57.2

842

3823

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.4

57.0

220

437

R2110

NOMESCO Finland

Giving the first information

2.0

56.5

822

3712

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

56.2

798

3572

I44.2

ICD-10 Finland

Atrioventricular block, complete

3.5

56.1

279

695

A10AE06

ATC

insulin degludec; parenteral

2.6

55.7

444

1517

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

55.5

185

315

B01AB05

ATC

enoxaparin; parenteral

1.4

55.4

4170

28428

H3600, E103

ICD-10 Finland

4.6

55.3

202

380

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

55.1

756

3337

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.1

54.7

158

226

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.7

54.7

257

611

EBA00

NOMESCO Finland

Extraction of tooth

1.4

54.6

4233

28980

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

54.5

433

1477

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

54.3

2655

16739

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

54.2

3751

25200

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

53.9

1470

8109

A10BK01

ATC

dapagliflozin; oral

2.0

53.7

705

3060

H3601, E103

ICD-10 Finland

5.0

53.6

183

320

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

53.6

1494

8291

N18.0

ICD-10 Finland

End-stage renal disease

4.6

53.1

194

365

K29

ICPC

Cardiovascular sympt/complt other

2.2

52.8

558

2202

S18

ICPC

Laceration/cut

1.3

52.6

5725

41220

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.4

52.5

202

401

I21.30

ICD-10 Finland

Acute transmural myocardial infarction with unspecified location no detected stenosis of coronary artery

475.1

52.4

N19

ICD-10 Finland

Unspecified kidney failure

2.8

52.4

360

1125

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

52.2

2073

12511

I20.8

ICD-10 Finland

Other forms of angina pectoris

10.1

52.2

109

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

52.1

575

2316

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

52.0

354

1101

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

52.0

1694

9771

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

3.7

51.9

241

568

GD1LA

NOMESCO Finland

4.0

51.7

220

480

V03AE01

ATC

polystyrene sulfonate; oral

4.4

51.5

196

385

SPAT1252

SPAT

Overall medication plan or its review

1.9

51.3

823

3853

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

+∞

51.2

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

51.1

2209

13565

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.4

51.0

262

670

PEN23

NOMESCO Finland

Plastic repair of femoral artery

5.9

50.8

150

221

FN2EA

NOMESCO Finland

Coronary rotablation

22.3

50.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

50.6

934

4588

WX722

NOMESCO Finland

PEEP

2.0

50.5

693

3060

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

+∞

50.2

M54.5

ICD-10 Finland

Low back pain

1.3

50.1

4261

29512

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.8

50.1

133

170

CKC15

NOMESCO Finland

Panretinal photocoagulation

5.8

50.1

149

222

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.5

50.0

418

1467

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.9

50.0

324

977

M48.0

ICD-10 Finland

Spinal stenosis

1.6

49.9

1601

9191

C10AA02

ATC

lovastatin; oral

2.4

49.9

445

1617

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

8.3

49.5

115

120

R50.9

ICD-10 Finland

Fever, unspecified

1.6

49.3

1601

9217

TFN40

NOMESCO Finland

Catheterisation of heart with balloon widening of coronary vessels

+∞

49.2

SPAT1255

SPAT

Intravenous administration of medicine

1.8

49.1

845

4053

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

49.0

611

2593

H36.01

ICD-10 Finland

Diabetic maculopathy

4.1

48.9

200

421

J01DA01

ATC

[U] cefalexin; systemic

1.3

48.7

8494

64954

A10BJ06

ATC

semaglutide; parenteral

2.2

48.6

527

2105

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.1

48.4

200

425

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.3

48.4

485

1868

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

48.2

1361

7565

R60.0

ICD-10 Finland

Localized oedema

1.6

48.2

1350

7487

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.7

47.9

353

1151

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.6

47.4

379

1298

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

47.4

1636

9552

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

12.5

46.9

L17

ICPC

Foot/toe symptom/complaint

1.4

46.9

3204

21388

H3600, E113

ICD-10 Finland

4.1

46.8

193

410

XPX08

NOMESCO Finland

Intraoperative flow measurement

6.4

46.4

128

173

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

46.3

262

719

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.4

46.2

178

354

J01MA02

ATC

ciprofloxacin; systemic

1.3

46.2

4981

35621

Z71.8

ICD-10 Finland

Other specified counselling

1.4

46.2

2771

18080

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

46.1

948

4816

1CX08

NOMESCO Finland

9.4

45.9

C07AB03

ATC

atenolol; systemic

2.0

45.9

667

3009

PD3AT

NOMESCO Finland

Pelvic artery PTA

6.8

45.8

122

157

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

112.6

45.8

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.6

45.7

344

1138

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

45.7

5436

39386

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.4

45.5

237

613

N05BA04

ATC

oxazepam; oral

1.4

45.2

3016

20030

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.5

45.1

170

331

N06AB04

ATC

citalopram; systemic

1.4

44.9

2762

18086

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.7

44.9

211

503

N06AA09

ATC

amitriptyline; systemic

1.6

44.8

1404

8004

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

44.8

2030

12556

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

44.5

2060

12794

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

4.4

44.5

171

340

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

44.4

1011

5294

4110X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Postmyocardial infarction syndrome[EPÄSTABIILI ANGINA PECTORIS,MÄÄRITTELEMÄT]

+∞

44.3

287

Kela drug reimbursment

Ticagrelor 60 mg

+∞

44.3

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.0

44.2

149

258

SPAT1260

SPAT

Consultation of another employee

1.4

44.2

2249

14227

L04AA06

ATC

mycophenolic acid; systemic

2.8

44.1

300

934

WX730

NOMESCO Finland

Conventional respirator

3.3

44.0

240

643

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

16.7

43.8

I95.1

ICD-10 Finland

Orthostatic hypotension

2.7

43.7

325

1068

WX882

NOMESCO Finland

High dependency care

2.5

43.7

356

1233

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

43.6

621

2780

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.0

43.4

265

767

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

43.4

187

414

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

43.2

3829

26558

N05BA01

ATC

diazepam; systemic, rectal

1.5

43.2

1748

10555

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

11.0

43.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

43.1

891

4531

E87.5

ICD-10 Finland

Hyperkalaemia

3.7

43.1

201

477

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.0

43.0

572

2494

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4739

18134

1.94

321.93

5.0

3.7

5.8

kpa

0.42

4587

17646

(3014576) Chloride [Moles/volume] in Serum or Plasma

6058

25133

1.81

320.53

8.8

6.8

104.3

mmol/l

0.01

5885

24621

(3002032) Base excess in Venous blood by calculation

4729

18131

1.94

319.20

5.0

3.7

1.8

1.9

mmol/l

0.70

3875

14923

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6736

27486

1.87

307.65

3.2

2.4

2.3

g/l

0.88

6270

25248

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7370

31848

1.77

307.65

2.0

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

7109

29633

1.84

307.65

3.2

2.4

11.3

13.6

umol/l

2.96

6609

27262

(3012544) pH of Venous blood

4960

18721

1.98

307.65

5.0

3.6

7.4

0.75

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10574

36420

2.48

307.65

6.9

3.2

1402.9

199.5

ng/l

29.63

9707

29519

(3032080) INR in Blood by Coagulation assay

17470

81383

2.04

307.65

12.4

9.2

1.3

inr

7.86

4616

22339

(3020779) Urea [Moles/volume] in Serum or Plasma

4867

17212

2.12

307.65

10.0

6.9

11.6

10.1

mmol/l

31.20

4615

16321

(3019060) Gas panel - Arterial blood

3947

12666

2.31

307.65

5.9

4.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

21028

112751

1.81

307.65

7.1

4.6

7.2

6.8

mmol/l

122.79

20204

105915

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5225

16439

2.42

307.65

3.9

2.6

308.2

176.7

ng/l

47.49

4858

14970

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15041

58029

2.46

307.65

4.1

2.8

2294.6

1221.3

ng/l

75.02

13650

49342

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7793

29071

2.12

307.65

2.6

2.0

31.2

29.7

55.30

7580

28236

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6450

25806

1.90

307.65

3.4

2.5

19.9

22.9

59.89

5506

21818

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3676

11784

2.30

307.65

8.7

6.7

24.5

24.7

mmol/l

4.15

3466

10988

(3016502) Oxygen saturation in Arterial blood

5810

19916

2.23

307.65

9.1

7.2

95.3

95.6

2.97

5589

19233

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8448

38325

1.70

307.65

2.2

1.7

1.3

1.4

mg/l

0.53

6624

29795

(3003396) Base excess in Arterial blood by calculation

6310

22345

2.18

307.65

8.8

6.9

1.0

1.1

mmol/l

0.56

4938

17840

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5259

18327

2.17

307.65

9.6

7.7

121.3

121.7

g/l

0.71

5089

17697

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6465

15246

3.40

307.65

3.1

2.1

10.7

5.9

ug/l

24.40

5769

12928

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12704

59430

1.78

307.65

2.6

2.1

238.7

212.7

u/l

1.79

11897

55480

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9869

46343

1.67

307.65

2.6

2.2

3.2

3.0

mg/l

11.98

8526

39051

(3027801) Oxygen [Partial pressure] in Arterial blood

6327

22319

2.19

307.65

8.7

6.9

11.5

12.3

kpa

29.02

6000

21319

(3023368) Bacteria identified in Blood by Culture

11588

54899

1.71

307.65

5.1

4.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2371

6623

2.59

307.65

3.5

2.8

0.3

0.4

u/ml

0.85

1513

3597

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6330

22336

2.19

307.65

8.7

6.9

5.0

5.1

kpa

7.77

6008

21348

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17021

73532

2.25

307.65

6.4

3.3

176.4

38.3

ng/l

6.07

13853

53846

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5332

21751

1.83

295.33

1.9

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

6328

27270

1.75

291.10

30.2

25.7

1.5

1.4

inr

4.38

772

3765

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5311

21845

1.81

285.39

1.9

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3447

12357

2.03

278.57

11.1

8.7

0.7

0.43

3422

12284

(3000991) Gas panel - Venous blood

4250

16536

1.89

270.93

10.5

7.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7039

31793

1.67

270.19

3.7

3.4

0.8

mmol/l

1.31

6556

29491

(3014007) Fractional oxyhemoglobin in Arterial blood

3436

12461

2.01

268.44

11.2

8.7

93.6

93.9

1.68

3421

12421

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3425

12409

2.01

268.30

10.8

8.6

1.4

2.84

3400

12326

(3020682) Albumin/Creatinine [Ratio] in Urine

12385

64305

1.53

263.06

4.3

4.0

14.8

8.1

mg/mmol

26.87

8220

40169

(3024354) Oxygen [Partial pressure] in Venous blood

3892

14855

1.92

262.25

4.0

3.0

4.6

4.5

kpa

1.40

3744

14391

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17799

100037

1.50

256.97

6.4

6.6

12.2

11.9

umol/l

2.00

16994

94754

(3012516) Albumin [Mass/volume] in Urine

11802

60953

1.53

254.49

3.5

3.2

371.3

417.4

mg/l

0.54

8047

38056

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3011

10667

2.04

249.81

12.1

9.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

4356

17541

1.82

247.59

8.8

6.6

1.4

1.3

mmol/l

5.15

4170

16921

(3004451) EKG impression Narrative

579

784

5.17

240.41

1.4

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5785

25531

1.69

238.32

8.0

5.6

1.1

1.0

mmol/l

45.26

5404

23628

(3018405) Lactate [Moles/volume] in Arterial blood

2087

6552

2.28

233.61

5.1

4.0

1.5

1.4

mmol/l

1.99

2048

6443

(3009508) Creatinine [Moles/volume] in Urine

11832

62325

1.49

223.96

3.4

3.2

7.2

7.6

mmol/l

18.52

9840

51675

(3043409) Potassium [Moles/volume] in Arterial blood

1809

5607

2.30

207.93

5.5

4.2

3.9

mmol/l

5.46

1690

5275

(3000963) Hemoglobin [Mass/volume] in Blood

27414

201923

0.61

203.01

36.2

22.5

132.3

136.0

g/l

248.50

27025

198538

(3004119) Hemoglobin [Mass/volume] in Venous blood

3100

11884

1.88

202.99

4.4

3.1

125.0

129.7

g/l

22.87

3011

11642

(3026361) Erythrocytes [#/volume] in Blood

27411

201884

0.61

202.17

35.9

22.4

4.4

4.5

e12/l

179.92

26617

195039

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2318

8041

2.06

201.66

6.2

4.7

1.7

1.6

2.96

2179

7584

(3024731) MCV [Entitic volume]

27412

201876

0.61

201.65

35.8

22.3

91.7

91.5

15.44

27018

198466

(3010813) Leukocytes [#/volume] in Blood

27418

201902

0.61

201.37

35.9

22.4

7.4

6.7

e9/l

252.92

26636

195095

(3035941) MCH [Entitic mass]

27410

201844

0.61

200.87

35.7

22.2

30.4

30.5

4.13

27016

198446

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2073

6925

2.14

198.74

2.9

2.2

655.9

553.5

ug/l

0.48

1990

6506

(3007461) Platelets [#/volume] in Blood

27409

201772

0.61

198.39

35.9

22.4

237.9

244.7

e9/l

51.54

26738

195694

(3027945) Reticulocytes/100 erythrocytes in Blood

5101

22874

1.64

193.17

2.4

2.5

1.9

1.8

15.27

4521

20066

(3007930) Methemoglobin/Hemoglobin.total in Blood

2262

7912

2.05

192.16

6.3

4.8

0.9

0.74

2130

7456

(3020891) Body temperature

2176

7645

2.03

182.34

6.2

4.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12569

69226

1.41

174.22

3.6

2.7

157.5

166.2

ug/l

2.19

11556

62791

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2757

10776

1.84

168.39

11.4

8.7

24.1

24.4

mmol/l

3.23

2520

10078

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16986

98933

1.39

166.33

9.6

6.6

1.2

mmol/l

114.99

14590

82584

(3027273) Bicarbonate [Moles/volume] in Venous blood

2515

9595

1.88

165.57

4.5

3.2

25.1

25.3

mmol/l

1.40

2447

9328

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2413

9127

1.89

162.99

5.3

4.0

23.9

24.2

mmol/l

4.14

2131

8212

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2403

9205

1.87

155.86

1.6

1.7

1.6

g/l

3.10

2066

7809

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2747

11001

1.79

154.39

1.6

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11039

60354

1.40

154.06

2.9

2.6

56.9

59.6

u/l

4.38

10266

55197

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15585

90254

1.37

152.30

8.8

5.9

1.2

mmol/l

119.78

14362

80952

(3047181) Lactate [Moles/volume] in Blood

1700

5858

2.06

149.27

7.6

5.6

1.4

1.3

mmol/l

2.20

1521

5197

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2881

11838

1.75

148.04

9.5

6.6

24.5

24.9

mmol/l

5.71

2854

11722

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2374

9273

1.83

144.37

3.4

2.7

1.3

1.2

0.61

2360

9228

(3018572) Chloride [Moles/volume] in Blood

1320

4187

2.23

142.73

8.3

6.4

105.0

104.9

mmol/l

0.42

1200

3799

(3039000) Anion gap in Blood

1320

4187

2.23

142.73

8.3

6.4

11.5

11.1

mmol/l

4.00

1200

3799

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2292

8891

1.84

142.42

5.2

3.8

49.3

47.9

1.86

2267

8797

(3023520) Reticulocytes [#/volume] in Blood

3860

17375

1.60

139.91

2.5

2.6

72.9

68.4

e9/l

10.60

2958

13163

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2312

9082

1.81

137.82

3.3

2.7

0.7

0.49

2229

8709

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2126

8269

1.83

130.61

2.1

2.0

1.9

2.2

ug/l

0.87

1900

7237

(3026008) Bacteria identified in Urine by Culture

10423

57833

1.36

125.95

3.8

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3226

14301

1.62

123.43

1.7

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

4570

21955

1.51

122.77

2.2

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

14671

85909

1.32

121.99

5.7

4.9

34.1

35.1

g/l

81.48

13646

79273

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4865

23736

1.49

121.10

4.1

4.4

253.6

243.4

u/l

2.97

4578

22383

(3019309) Folate [Moles/volume] in Red Blood Cells

7357

38822

1.40

119.87

1.9

1.8

1182.3

1153.4

nmol/l

1.71

5682

28673

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26915

196150

0.70

114.81

14.0

11.0

28.5

26.4

u/l

12.21

26048

188237

(3020564) Creatinine [Moles/volume] in Serum or Plasma

26977

196451

0.70

113.04

29.5

17.9

91.1

80.2

umol/l

203.20

26968

196373

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10352

58142

1.33

111.96

3.3

40.0

35.1

u/l

2.92

9763

54766

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2880

12753

1.61

109.99

4.5

3.5

5.1

5.2

kpa

2.06

2676

11700

(3009343) pH of Capillary blood

2838

12597

1.61

107.20

4.5

3.5

7.4

0.72

411

1677

(3024928) Oxygen saturation in Venous blood

1174

3982

2.07

106.92

4.0

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

7707

41617

1.36

106.92

3.1

2.6

4.9

e6/l

0.16

6846

36251

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2747

12156

1.61

104.95

4.5

3.4

1.8

mmol/l

0.15

2027

9152

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14652

86979

1.29

103.43

4.7

4.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

244

328

5.16

102.19

8.8

7.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1502

5676

1.87

100.41

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

8861

49311

1.33

99.23

5.1

4.0

83.2

88.2

59.93

8642

48175

(21494755) Public health laboratory ask at order entry panel

849

11926

0.48

96.70

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1319

4836

1.92

96.56

2.4

2.3

139.9

106.6

ug/min

1.74

801

2778

(3026493) Urate [Moles/volume] in Serum or Plasma

9304

52304

1.32

96.41

3.2

2.7

4335.5

5240.9

umol/l

1.25

7963

44828

(3030467) Casts [#/volume] in Urine by Automated count

9773

55334

1.31

96.14

3.8

3.2

0.5

0.4

e6/l

2.39

7699

41470

(3028626) Oxygen [Partial pressure] in Capillary blood

1188

4229

1.97

94.71

3.4

2.8

7.9

8.0

kpa

1.72

1114

3899

(3002582) Erythrocytes [#/volume] in Urine

10507

60213

1.30

94.01

3.9

3.3

92.3

96.8

e6/l

0.13

8409

46083

(3010421) pH of Blood

1361

5164

1.85

89.68

5.0

3.8

7.4

2.07

1170

4439

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1169

4221

1.95

89.42

3.2

3.1

0.8

nmol/l

1.29

891

3274

(3042936) Bacteria identified in Isolate by Culture

5342

27874

1.39

89.21

2.5

2.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1328

5009

1.86

89.13

3.8

2.9

24.6

24.9

mmol/l

1.37

1171

4385

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2682

12260

1.56

88.56

1.8

1.7

—

(36304419) Bacteria [Presence] in Urine

9343

53208

1.30

85.64

3.7

3.2

—

(3026782) Osmolality of Urine

7122

39104

1.33

84.99

3.3

2.8

536.3

555.5

mosm/kgh2o

11.05

6182

33155

(3038071) Oxygen [Partial pressure] in Mixed venous blood

207

291

4.93

82.73

8.7

7.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

996

12616

0.53

81.76

2.1

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

23953

175910

0.77

80.21

22.9

14.5

72.5

77.1

ml/min/173m2

183.21

20555

145339

(3018418) pH of Serum or Plasma

10175

58993

1.28

79.62

5.2

4.2

7.4

0.51

1991

11157

(3044640) Blood type and Crossmatch panel - Blood

10375

60324

1.27

79.23

3.0

2.5

—

(3018095) Leukocytes [#/volume] in Urine

11646

68678

1.26

79.06

4.4

3.8

111.2

106.3

e6/l

0.20

8899

49291

(3006315) Basophils [#/volume] in Blood

15147

92102

1.25

78.87

6.2

5.9

0.0

e9/l

2.53

13022

78542

(3021901) Oxygen saturation in Capillary blood

1013

3641

1.95

78.44

3.3

2.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

289

556

3.61

78.24

7.5

5.0

25.4

25.0

mmol/l

0.58

252

518

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1291

5030

1.80

78.00

2.9

2.4

3.7

g/l

0.03

1239

4808

(40767503) Oxygen content in Capillary blood by calculation

1145

4299

1.87

77.83

3.0

2.5

15.9

16.4

3.05

578

2275

(3012501) Base excess in Blood by calculation

1195

4549

1.84

77.81

5.1

3.9

2.5

2.6

mmol/l

1.31

817

3153

(3027315) Oxygen [Partial pressure] in Blood

1201

4580

1.84

77.76

5.1

3.9

8.5

kpa

0.12

1173

4468

(3013290) Carbon dioxide [Partial pressure] in Blood

1195

4551

1.84

77.70

5.1

3.9

5.0

kpa

1.27

1167

4440

(3001604) Monocytes [#/volume] in Blood

15056

91582

1.25

77.65

6.2

5.9

0.7

0.6

e9/l

69.52

12926

78059

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4198

21524

1.40

76.62

2.6

2.8

8.9

9.8

umol/l

1.72

3685

18895

(3022806) Fractional oxyhemoglobin in Capillary blood

759

2500

2.12

74.45

2.1

1.8

89.1

89.4

0.55

746

2465

(3013115) Eosinophils [#/volume] in Blood

15501

94898

1.24

73.94

6.4

6.1

0.2

e9/l

12.81

13521

81955

(3019198) Lymphocytes [#/volume] in Blood

15353

93894

1.24

73.93

6.3

6.0

1.8

1.9

e9/l

2.40

13383

81378

(3044889) 12 lead EKG panel

21124

134055

1.25

71.22

5.9

3.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3024

14819

1.45

70.59

5.1

3.7

123.0

89.9

ng/l

37.16

2604

12536

(1616796) Gas panel - Central venous blood

1150

4470

1.80

69.95

4.6

3.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

884

3183

1.94

68.07

2.2

1.8

1.7

mmol/l

0.16

866

3106

(3013650) Neutrophils [#/volume] in Blood by Automated count

17120

106574

1.23

66.72

8.7

9.5

4.7

4.2

e9/l

111.19

14895

92282

(40768804) Tissue Pathology biopsy report

9492

76406

0.80

66.60

2.1

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13601

82691

1.23

66.33

2.2

2.0

92.4

94.8

pmol/l

7.02

7365

42800

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

159

218

5.05

65.37

8.1

6.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1067

4184

1.79

63.00

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1067

4186

1.78

62.90

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1729

17873

0.65

62.58

1.3

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3426

17554

1.39

61.76

2.4

2.7

65.5

66.4

g/l

9.06

3104

15829

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

764

2706

1.97

61.67

7.4

6.0

12.1

11.7

mg/l

1.51

697

2481

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

582

8004

0.49

61.49

1.6

1.5

—

(3036489) Thrombin time

1497

6486

1.62

61.32

2.6

1.9

22.7

21.6

3.83

1367

5712

(3022096) Basophils/100 leukocytes in Blood

13690

83878

1.22

59.50

6.5

6.2

0.6

0.7

12.06

12809

77728

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1146

4668

1.72

59.31

3.1

2.4

218.5

198.9

9.57

1095

4408

(3022313) Gas panel - Capillary blood

1978

9207

1.51

59.26

4.8

3.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3414

17649

1.37

58.06

2.8

2.5

57.1

46.9

u/l

0.20

2921

15096

(3006504) Eosinophils/100 leukocytes in Blood

14022

86258

1.21

57.93

6.5

6.2

2.9

0.06

13112

79882

(3019069) Monocytes/100 leukocytes in Blood

14087

86753

1.21

57.31

6.8

6.5

9.0

8.9

3.52

13203

80638

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

22834

147436

1.23

57.17

8.8

7.8

82.1

79.5

u/l

10.63

21692

138142

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7979

46335

1.25

57.14

2.8

2.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

8094

47127

1.25

56.49

1.7

1.5

19.2

20.5

nmol/l

9.57

7067

39626

(40761535) Cells panel - Urine sediment

3183

16344

1.38

56.32

4.1

3.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1119

4610

1.70

55.56

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1226

5179

1.66

55.41

3.0

2.1

87.1

89.7

3.32

1171

4826

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1085

4448

1.71

54.84

1.5

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

19419

123680

1.21

53.94

5.7

4.7

1584.3

1426.5

e6/l

0.14

343

1862

(3023183) Ammonium ion [Moles/volume] in Plasma

1044

4269

1.71

53.26

2.4

2.8

32.0

34.7

umol/l

2.90

863

3593

(1761868) Lipid panel - Serum or Plasma

7407

60061

0.81

51.80

4.1

3.0

—

(40761511) CBC panel - Blood by Automated count

26268

188834

0.79

51.72

24.0

14.2

—

(3013512) EKG study

9985

59891

1.22

51.42

6.2

3.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

14268

88574

1.20

50.99

6.7

6.3

24.7

27.0

106.46

13273

81836

(3018010) Neutrophils/100 leukocytes in Blood

14060

87173

1.20

50.91

6.4

6.0

59.8

57.8

71.16

13132

80919

(3008037) Lactate [Moles/volume] in Venous blood

1085

4559

1.66

50.02

4.4

3.1

1.7

1.6

mmol/l

1.05

1060

4466

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

768

2946

1.82

48.74

1.4

—

(42870588) Differential panel, method unspecified - Blood

10776

65373

1.21

48.62

6.2

6.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6101

34899

1.25

48.56

3.2

2.9

1.2

e6/l

0.02

3710

19887

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1091

4637

1.65

48.12

2.5

2.2

127.3

129.9

g/l

2.37

836

3270

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1779

8452

1.48

48.02

1.5

17.2

17.3

u/ml

0.01

222

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2955

15383

1.36

47.54

3.4

2.7

55.8

63.7

ml/min/173m2

23.10

1354

6059

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

850

3419

1.73

45.98

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

695

2634

1.84

45.86

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

690

2618

1.84

45.37

1.5

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3783

20545

1.31

45.35

4.6

3.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

282

748

2.62

44.99

11.1

3.6

770.5

2351.9

mg/l

0.88

215

511

(3040151) Glucose [Moles/volume] in Capillary blood

600

2192

1.91

44.33

10.6

8.2

7.7

7.4

mmol/l

1.05

491

1800

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1450

6772

1.50

42.49

2.8

3.4

2.3

4.7

ratio

0.93

488

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1482

6967

1.49

42.06

2.8

3.5

42.9

45.9

mg/l

0.32

1186

5652

(3038515) Glucose [Moles/volume] in Venous blood

1014

4378

1.62

42.01

4.6

3.1

8.0

7.6

mmol/l

4.30

992

4298

(3034860) Kappa light chains.free [Mass/volume] in Serum

1483

6976

1.49

41.96

2.8

3.5

102.8

59.0

mg/l

0.58

1186

5655

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7099

41836

1.22

41.80

1.8

1.7

36470208.1

31649948.0

pmol/l

0.26

5824

33713

(3003434) Protein [Mass/volume] in Pleural fluid

731

2897

1.76

41.66

1.6

1.5

29.3

33.7

g/l

14.09

638

2616

(3052851) Hemolysis interference index of Serum or Plasma

1300

5977

1.52

41.01

4.6

3.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

1154

5173

1.56

40.82

2.8

3.6

—

(3041354) Potassium [Moles/volume] in Venous blood

672

2626

1.78

40.17

3.0

2.3

4.1

mmol/l

4.13

664

2607

(3035285) Chloride [Moles/volume] in Venous blood

672

2626

1.78

40.17

3.0

2.3

105.7

105.5

mmol/l

0.58

664

2607

(3004588) Protein electrophoresis panel - Serum or Plasma

2784

14743

1.33

39.62

2.2

2.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

26024

186327

0.82

39.34

7.0

5.1

2.1

2.8

mmol/l

307.65

24389

168801

(3033705) Calcium.ionized [Moles/volume] in Venous blood

660

2596

1.77

38.61

3.0

2.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1698

8335

1.43

38.47

2.0

—

(40758558) Short blood count panel - Blood

7864

47156

1.20

37.95

6.8

7.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1581

7685

1.44

37.76

1.9

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

819

3442

1.66

37.75

1.5

1.7

—

(3019150) Specific gravity of Urine by Refractometry

6688

39540

1.21

37.43

5.2

4.2

1.0

kg/l

0.75

1106

5956

(3044242) Glucose [Moles/volume] in Arterial blood

295

877

2.33

37.18

1.8

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5586

32486

1.23

36.79

3.4

3.0

2.3

e6/l

0.02

3259

17576

(3009542) Hematocrit [Volume Fraction] of Blood

22398

162184

0.85

36.01

26.5

16.5

38.2

39.7

63.79

13745

108606

(3023103) Potassium [Moles/volume] in Serum or Plasma

27318

194312

0.82

35.11

31.3

17.6

4.0

mmol/l

188.94

26809

189098

(3023199) Leukocytes [#/volume] in Pleural fluid

642

2577

1.73

35.05

1.5

2626.9

3432.1

e6/l

0.42

475

1863

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1361

6532

1.46

34.74

1.7

1.6

224.3

266.9

titre

0.28

266

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1623

8058

1.41

34.45

5.2

3.8

24.7

24.9

mmol/l

2.62

1497

7382

(3011397) Hemoglobin [Presence] in Urine by Test strip

7333

44016

1.19

34.36

4.4

3.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2909

15809

1.30

34.11

2.2

2.4

370.9

374.1

nmol/l

0.29

2660

14495

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1061

4863

1.52

33.95

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

674

2778

1.69

33.47

1.4

1.5

—

(44806118)

520

2010

1.80

32.32

1.5

1.6

—

(44790048)

520

2011

1.80

32.26

1.5

1.6

—

(44790047)

520

2011

1.80

32.26

1.5

1.6

—

(44790049)

520

2011

1.80

32.26

1.5

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

388

4924

0.54

31.59

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1482

7376

1.40

30.99

2.8

2.7

—

(3051651) Icteric interference index of Serum or Plasma

331

1114

2.06

30.95

5.4

3.8

—

(3023419) Bacteria identified in Sputum by Culture

621

2564

1.68

30.67

2.1

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

27300

193824

0.83

30.61

31.1

17.5

139.4

139.7

mmol/l

53.89

26834

188894

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

25405

181493

0.85

30.51

6.0

4.9

6.4

6.0

mmol/l

253.25

23234

163328

(3036782) Glucose [Moles/volume] in Pleural fluid

499

1942

1.79

30.35

1.4

7.2

6.2

mmol/l

8.97

457

1793

(3019977) pH of Arterial blood

324

1094

2.05

30.06

2.5

7.4

0.93

105

421

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3373

18951

1.25

29.98

2.1

2.3

0.2

g/l

4.67

3081

17543

(3001019) Free T4 and TSH panel - Serum or Plasma

465

5528

0.57

29.98

1.7

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

578

2357

1.70

29.89

1.5

50591.3

60570.8

e6/l

0.30

360

1398

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

547

2197

1.73

29.87

1.5

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

490

1916

1.78

29.35

3.3

2.8

—

(3017569) Oxygen content in Arterial blood

274

877

2.17

29.16

1.8

2.3

—

(3045788) Cell count panel - Pleural fluid

498

1961

1.76

29.14

1.5

—

(3045716) Anion gap in Serum or Plasma

256

803

2.21

28.63

1.9

2.5

9.0

9.1

mmol/l

0.18

187

574

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

419

1581

1.84

28.21

1.6

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

691

3006

1.60

27.85

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

838

3812

1.53

27.81

1.3

1.2

89.3

144.6

titre

0.78

(3035350) Ketones [Presence] in Urine by Test strip

14180

90768

1.14

26.49

4.6

3.7

0.0

estimate

1.23

2627

16275

(4094501)

1100

5346

1.43

26.28

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

542

2260

1.67

25.87

1.5

—

(3004775) Volume in Urine collected for unspecified duration

423

1646

1.78

25.82

2.3

2.2

663.8

687.4

0.50

285

1078

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3106

17578

1.24

25.67

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

19757

129336

1.14

25.64

5.3

4.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

25553

181922

0.86

25.32

6.1

4.6

3.9

4.7

mmol/l

307.65

24018

165565

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

279

3632

0.53

24.81

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

14319

92056

1.13

24.07

4.7

3.8

0.0

estimate

0.22

2482

16160

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

484

2007

1.67

23.64

1.4

1.3

302.4

512.6

u/l

3.79

456

1905

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1104

5479

1.40

23.48

1.6

1.4

14.3

14.4

iu/ml

0.01

126

(3026250) Tacrolimus [Mass/volume] in Blood

231

756

2.12

23.38

36.6

34.2

7.4

7.3

ug/l

0.36

211

676

(3017143) Hepatitis C virus Ab [Presence] in Serum

2788

15793

1.24

22.73

1.8

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

868

4148

1.46

22.71

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1032

5100

1.41

22.50

1.6

1.5

1.2

g/l

0.95

976

4839

(3042733) HLA Ab [Presence] in Serum

192

593

2.24

22.41

5.0

4.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

788

7814

0.69

22.39

3.2

4.0

104.0

68.0

u/ml

0.76

756

7497

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

411

1655

1.72

22.38

1.2

1.3

1.5

1.4

nmol/l

2.06

370

1497

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

712

3285

1.51

22.20

1.2

1.3

30.2

38.1

u/l

1.41

624

2832

(3021601) Nitrite [Presence] in Urine by Test strip

14122

91013

1.12

22.03

6.0

5.0

0.0

estimate

1.60

2674

16587

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1015

5022

1.41

21.98

3.5

2.9

2.0

1.6

mg/l

30.66

915

4563

(21494890) Protein electrophoresis panel - 24 hour Urine

524

2261

1.61

21.94

1.8

2.1

—

(3025941) Bacteria identified in Stool by Culture

1737

9340

1.30

21.82

1.3

—

(3021589) Normoblasts [#/volume] in Blood

12680

81266

1.13

21.55

12.7

10.1

0.0

e9/l

0.52

10374

66491

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

997

4936

1.41

21.52

1.6

1.5

0.2

g/l

1.78

941

4661

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

589

2628

1.56

21.42

1.4

1.3

0.2

0.3

nmol/l

0.15

210

(3000330) Specific gravity of Urine by Test strip

1856

10096

1.28

21.33

4.2

3.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1172

5978

1.37

21.16

1.9

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

492

2117

1.61

20.87

5.0

3.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1471

7786

1.32

20.74

2.2

2.4

10.0

10.3

g/l

1.62

1217

6453

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

585

2629

1.55

20.62

1.4

1.3

2.4

1.4

nmol/l

0.24

560

2515

(3029937) Albumin [Presence] in Urine by Test strip

7911

49349

1.14

20.47

5.2

4.2

0.0

estimate

0.28

2451

15810

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2835

16281

1.22

20.19

1.8

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

423

1776

1.65

19.80

1.9

2.3

0.8

g/24h

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

25396

180233

0.88

19.79

6.1

4.5

1.3

1.5

mmol/l

307.65

23705

162963

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1549

8313

1.30

19.74

2.2

2.4

3.8

3.9

g/l

0.25

1108

5867

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

262

956

1.90

19.74

2.3

2.1

231.3

76.9

ug/min

0.84

219

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

330

1298

1.76

19.57

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1552

8341

1.30

19.57

2.2

2.4

7.8

7.4

g/l

10.91

1124

6159

(3016750) Collection duration of Urine

306

1177

1.80

19.55

2.2

2.1

498.0

498.6

min

0.04

223

841

(40768806) Pleura Pathology biopsy report

520

2304

1.57

19.54

1.5

1.6

—

(3002256) Pathology report gross observation

3165

25713

0.83

19.43

1.3

—

(3037756) Immunofixation for Serum or Plasma

937

4677

1.39

19.32

1.5

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1548

8333

1.30

19.28

2.2

2.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

697

3304

1.47

19.08

4.7

3.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1769

9704

1.27

19.00

3.2

3.3

4.3

4.4

pmol/l

8.31

1558

8533

(40757494) Bilirubin.total [Moles/volume] in Blood

279

1057

1.83

18.75

1.9

2.2

33.2

28.4

umol/l

0.15

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

536

2420

1.54

18.56

1.4

1.3

—

(3035880) pH of Pleural fluid

303

1183

1.77

18.46

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1889

10490

1.26

18.30

1.8

2.0

1.2

1.4

g/l

2.56

1704

9464

(40768797) Stomach Pathology biopsy report

4404

26557

1.17

17.99

1.3

—

(3017704) Immunofixation for Urine

293

1147

1.77

17.72

1.3

1.7

—

(3022621) pH of Urine by Test strip

2175

12315

1.23

17.70

3.5

3.0

—

(4035726)

2225

18499

0.82

17.33

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2350

13456

1.22

17.16

2.6

2.9

10.5

10.6

g/l

0.64

2172

12246

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

924

4697

1.37

17.10

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

110

3.71

17.05

2.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

499

2277

1.52

16.52

1.4

1.3

—

nmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

516

5216

0.68

16.34

2.3

1.7

4.7

3.7

mg/l

0.90

407

3747

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

624

2989

1.45

16.26

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

581

2.05

16.21

3.0

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

581

2.05

16.21

3.0

2.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1430

7804

1.28

16.02

2.2

2.4

3.2

3.1

g/l

4.26

1113

6003

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

683

3336

1.42

16.02

1.6

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

3769

22657

1.17

15.89

1.3

504.9

527.2

titre

0.33

850

4753

(40768793) Breast Pathology biopsy report

330

3638

0.62

15.85

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1912

10830

1.23

15.49

2.6

2.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1002

9020

0.76

15.44

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

575

5636

0.70

15.39

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

809

4097

1.37

15.37

1.5

1.6

—

(3011985) Renin [Units/volume] in Plasma

532

2499

1.48

15.35

1.3

1.4

96.9

60.9

mu/l

1.66

474

2203

(3017181) Myelocytes/100 leukocytes in Blood

2772

16289

1.19

15.35

4.0

0.9

1.0

1.12

860

4991

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

616

2978

1.44

15.31

1.6

1.4

123.3

112.9

u/ml

0.93

134

662

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1086

5752

1.31

15.30

2.3

2.4

0.0

g/l

0.28

982

5211

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2055

17007

0.82

15.21

2.2

12.1

13.0

nmol/l

5.15

1783

15045

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

300

1240

1.68

15.04

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

745

3736

1.38

15.04

1.4

1.3

60.8

61.8

mmol/l

0.29

597

2964

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1149

6152

1.30

14.95

2.3

2.4

0.0

g/l

0.40

1041

5594

(3014891) Appearance of Pleural fluid

257

2.56

14.95

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1067

5658

1.31

14.91

2.3

2.4

0.0

g/l

0.00

975

5196

(3014765) Yersinia sp identified in Stool by Organism specific culture

963

5040

1.33

14.77

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

259

1034

1.73

14.74

1.3

1.2

nmol/l

0.85

201

788

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2807

16572

1.18

14.72

5.2

3.9

1.2

mmol/l

19.46

2540

14293

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6461

48932

0.89

14.64

2.9

3.0

0.8

ug/l

0.11

4544

32879

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

772

3914

1.37

14.59

1.8

1.6

0.9

0.8

nmol/l

3.44

624

3266

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1199

6478

1.29

14.57

2.2

2.3

36.5

37.5

g/l

7.10

1026

5486

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

281

1152

1.69

14.55

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

963

5052

1.33

14.54

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

280

1148

1.69

14.49

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

121

372

2.25

14.48

1.2

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

669

3317

1.40

14.46

1.5

1.4

20.7

15.6

u/ml

0.44

(46235355) HIV 1 and 2 tests - Meaningful Use set

3147

18785

1.17

14.44

1.8

1.5

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

276

2.45

14.23

1.6

1.5

129.0

110.1

ug/l

0.83

214

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

951

4999

1.32

14.17

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

762

3875

1.37

14.15

5.9

5.7

2070.3

2138.3

iu/ml

0.02

128

625

(3003338) MCHC [Mass/volume]

20964

149538

0.91

13.89

32.4

19.8

331.2

332.5

g/l

74.85

20725

148467

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4167

25473

1.15

13.89

11.9

7.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10734

69334

1.10

13.77

5.1

4.0

—

(3025159) Blasts/100 leukocytes in Blood

2457

14424

1.19

13.73

4.0

4.1

0.0

0.3

4.06

692

3895

(3052592) Norovirus Ag [Presence] in Stool

117

367

2.20

13.39

1.5

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

898

4722

1.32

13.37

1.2

114.6

134.3

titre

0.31

384

(3002179) Metamyelocytes/100 leukocytes in Blood

2496

14710

1.19

13.33

3.8

3.9

0.6

0.7

0.52

633

3590

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

125

1708

0.50

13.22

1.3

64.4

94.5

pmol/l

0.89

561

(3016038) Potassium [Moles/volume] in Urine

307

1323

1.61

13.15

1.2

1.1

35.5

34.6

mmol/l

0.25

253

1121

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

252

1036

1.68

12.98

1.8

1.9

—

(3034770) Mitochondria Ab [Titer] in Serum

887

4683

1.32

12.85

1.2

798.9

889.8

titre

0.21

128

(3021440) Promyelocytes/100 leukocytes in Blood

2606

15467

1.18

12.79

4.0

4.1

0.1

2.96

800

4638

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

439

2062

1.48

12.77

1.2

54.6

61.9

u/l

1.47

299

1371

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

364

1645

1.53

12.73

1.3

13.0

13.7

u/l

0.15

320

1535

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

323

1421

1.57

12.72

1.2

172.1

138.1

titre

0.35

235

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

440

2073

1.47

12.61

1.4

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1280

7098

1.25

12.60

2.4

2.6

0.7

1.0

g/l

2.20

1092

5988

(3010375) cycloSPORINE [Mass/volume] in Blood

213

843

1.75

12.58

23.7

30.0

107.0

114.6

ug/l

0.87

158

722

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

322

1420

1.57

12.55

1.2

102.5

157.1

titre

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

210

2.57

12.47

1.3

1.2

7.8

230778.4

nmol/l

1.11

169

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

259

2841

0.63

12.29

3.4

3.5

37.1

43.9

u/ml

0.48

241

2761

(4010399)

2413

14291

1.18

12.15

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

194

760

1.77

11.90

1.5

1.4

63.7

62.9

0.12

146

626

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

482

2340

1.43

11.83

1.3

1.2

5.2

3.7

u/ml

1.22

218

1053

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

481

2341

1.42

11.66

1.3

242.0

290.1

pmol/l

1.75

364

1790

(3051593) INR in Capillary blood by Coagulation assay

252

1067

1.63

11.65

11.2

10.2

—

(3000492) Spirometry study

2736

16428

1.16

11.59

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

411

1947

1.46

11.50

1.4

1.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

294

2.23

11.31

2.2

1.7

1.2

mmol/l

1.10

283

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

909

4904

1.29

11.26

1.9

2.0

12.4

11.5

mg/l

0.91

843

4519

(3037121) Protein [Mass/volume] in Urine

1234

6912

1.24

11.15

3.0

3.2

0.4

0.3

g/l

2.69

572

3038

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

372

1740

1.48

11.12

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

372

1740

1.48

11.12

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

372

1740

1.48

11.12

1.4

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

302

3130

0.66

11.03

1.5

1.4

211.1

190.8

pmol/l

0.21

296

3047

(3014051) Protein [Presence] in Urine by Test strip

788

4186

1.31

10.98

2.6

2.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

789

4200

1.30

10.84

1.3

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

213

881

1.67

10.82

2.1

93.0

97.0

0.91

207

835

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

553

2798

1.37

10.72

1.2

314.6

286.7

u/ml

1.03

357

1777

(3000093) Morphology [Interpretation] in Blood Narrative

407

1961

1.44

10.48

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

300

1360

1.53

10.45

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

453

2228

1.41

10.41

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

337

1572

1.48

10.26

1.4

14.4

12.7

u/l

4.24

322

1513

(3034988) Calcium [Moles/volume] in Capillary blood

317

2.11

10.16

2.4

1.7

1.2

mmol/l

0.72

303

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1353

7759

1.21

9.78

1.8

1.9

36.6

39.2

u/l

4.21

1118

6752

(3041918) Cholesterol [Moles/volume] in Pleural fluid

112

396

1.96

9.54

1.3

1.2

1.3

1.8

mmol/l

2.63

236

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

291

1338

1.51

9.54

1.3

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5927

37768

1.10

9.39

5.1

4.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

572

2973

1.33

9.38

2.6

2.7

1098.7

6490.3

u/ml

0.98

184

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

140

537

1.80

9.33

1.5

1.4

20.6

23.3

0.54

116

455

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.68

9.32

13.0

13.6

—

(40757373) Influenza virus identified in Isolate

108

381

1.96

9.27

1.4

1.8

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

247

2.21

9.27

1.4

76.9

71.6

0.84

206

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1061

5971

1.23

9.25

1.4

255.7

263.1

ug/g

0.57

650

3559

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

578

3016

1.33

9.23

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

1292

0.53

9.22

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

270

2.15

9.22

1.3

42.8

334.2

u/l

1.02

193

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

212

917

1.60

9.12

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

270

1235

1.51

9.09

1.2

11.9

12.3

mmol/l

0.29

108

420

(40762365) Oxygen content in Arterial blood by calculation

103

361

1.97

9.02

2.9

3.2

14.7

ml/dl

0.02

341

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

773

4210

1.27

8.98

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

235

1046

1.55

8.96

3.6

—

(3012565) Volume of 24 hour Urine

222

976

1.57

8.93

2.3

2.2

1850.0

1935.4

0.55

191

856

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

251

1137

1.53

8.86

1.5

1.4

15.6

13.3

umol/l

3.69

229

1077

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1824

10844

1.17

8.79

3.4

2.8

0.3

e6/l

0.56

1790

10627

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.04

8.77

4.4

3.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

151

605

1.73

8.72

1.9

1.8

170.8

169.1

0.08

140

563

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

260

1192

1.51

8.69

1.2

102.5

91.2

u/l

0.89

228

1030

(3008116) Ketones [Moles/volume] in Urine by Test strip

105

376

1.93

8.67

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

253

1155

1.52

8.63

1.2

28.5

26.5

u/l

0.24

219

981

(3026389) Candida sp identified in Specimen by Organism specific culture

483

2493

1.34

8.36

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.18

8.28

14.0

9.1

108.3

311.3

e6/l

0.79

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

320

1.99

8.27

1.6

1.4

11.3

10.8

0.07

164

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

181

773

1.62

8.25

4.2

2.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

418

2119

1.37

8.14

3.3

3.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

992

5622

1.22

8.14

4.9

4.2

—

(40768446) Kidney Pathology biopsy report

172

728

1.63

8.14

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

120

460

1.80

8.08

5.0

6.9

70.6

70.1

0.08

365

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

546

2886

1.31

8.03

1.7

1.9

23.8

24.0

ug/l

0.02

527

2827

(3020191) Ethanol [Moles/volume] in Serum or Plasma

300

1449

1.43

7.76

1.4

1.3

1.4

promille

0.17

222

1115

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

107

401

1.84

7.76

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1363

11006

0.85

7.67

1.3

53.4

54.7

au/ml

0.05

483

(3042631) Mycobacterium sp identified in Specimen

571

3057

1.29

7.66

2.7

2.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

829

1.57

7.56

2.2

2.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

188

2.24

7.49

1.3

1.1

—

(3025315) Body weight

163

2.33

7.38

6.1

4.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

102

384

1.84

7.32

3.0

2.3

—

(40768795) Lymph node Pathology biopsy report

202

2079

0.67

7.30

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

163

701

1.61

7.29

1.4

1.3

3.3

3.5

mmol/l

0.42

144

648

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3373

25574

0.90

7.29

5.7

4.7

33.3

32.2

7.91

2679

16492

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

486

1.74

7.27

1.5

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

155

659

1.63

7.26

1.5

1.4

3.0

2.5

0.26

120

555

(3048929) Epstein Barr virus Ab [Presence] in Serum

698

3858

1.25

7.26

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

464

2436

1.32

7.22

1.3

1.2

2.8

4.3

u/ml

1.45

157

842

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

690

5906

0.80

7.21

1.7

41.8

42.3

nmol/l

0.27

661

5727

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1526

12147

0.86

7.16

2.4

32.4

28.2

au/ml

0.31

526

(3000012) Reticulocyte production index

249

1181

1.46

7.14

1.6

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

163

705

1.60

7.13

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

213

981

1.50

7.07

1.2

1.1

2.9

3.6

iu/ml

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

221

1027

1.49

7.03

1.3

1.2

249.5

355.7

u/l

0.86

212

940

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

255

1222

1.44

6.94

1.6

1.5

6.0

6.8

u/l

0.37

125

587

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

983

5662

1.20

6.91

1.4

—

(4034850)

1037

6009

1.20

6.83

15.5

9.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

263

2545

0.71

6.81

1.4

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

523

2819

1.28

6.73

1.5

1.6

0.8

0.9

g/l

1.11

394

2082

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

6.90

6.69

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

149

2.32

6.67

1.4

2.1

0.7

1.1

mmol/l

0.90

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

195

894

1.51

6.64

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5792

37391

1.08

6.63

3.1

3.3

2.5

mmol/l

2.22

4928

32751

(3049717) Cytology report of Urine Cyto stain

1486

8899

1.16

6.59

2.7

2.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

317

1597

1.37

6.52

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

494

2657

1.29

6.48

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

264

1291

1.41

6.47

2.7

2.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

875

0.53

6.42

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

204

952

1.48

6.40

2.5

2.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

206

2.08

6.40

1.2

1.1

14.6

18.0

g/l

2.78

185

(3024932) HLA-DR beta [Type]

140

606

1.60

6.18

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.15

6.13

5.6

5.5

435.0

428.2

umol/l

0.06

(3000919) Neutrophils/100 leukocytes in Pleural fluid

136

586

1.60

6.12

1.5

1.4

20.9

20.4

0.08

114

535

(3033923) Metanephrine [Moles/time] in 24 hour Urine

101

403

1.73

6.07

1.1

17.5

0.7

umol/24h

0.52

189

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7709

50460

1.07

6.03

1.8

1.6

1.4

mmol/l

2.99

6479

41493

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

321

1645

1.35

5.97

1.9

2.1

2.3

2.4

u/field

0.11

129

658

(3042010) Triglyceride [Moles/volume] in Pleural fluid

319

1.82

5.96

1.3

0.5

1.6

mmol/l

2.83

207

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

162

733

1.53

5.92

1.8

77.9

117.6

umol/l

1.99

383

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

875

5067

1.20

5.87

1.8

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

361

1.76

5.87

1.2

64.6

30.4

mg/l

0.22

277

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

211

1011

1.44

5.83

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

211

1011

1.44

5.83

1.3

1.5

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

3.63

5.80

7.7

9.7

42.6

50.1

0.51

(1002224) Polysomnography panel

791

6526

0.83

5.80

1.0

1.1

—

(3024471) HLA-A [Type]

141

624

1.56

5.70

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

522

2877

1.26

5.67

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

554

3081

1.25

5.57

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

251

1252

1.39

5.56

1.6

74.7

73.9

umol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

13250

94517

0.95

5.54

2.5

2.4

—

(4268621)

303

1559

1.34

5.53

2.4

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

213

1036

1.42

5.46

1.2

—

(4306422)

429

2321

1.28

5.45

1.3

1.2

—

(4281824)

205

1977

0.71

5.31

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

281

1.82

5.30

1.4

1.2

86.7

84.5

0.16

(3015377) Calcium [Moles/volume] in Serum or Plasma

10040

66507

1.06

5.27

3.4

3.5

2.3

2.4

mmol/l

12.99

8621

57054

(3045414) Leukocytes [Presence] in Urine

1387

8413

1.14

5.22

2.3

1.9

—

(3003694) ABO and Rh group [Type] in Blood

6603

48036

0.94

5.22

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

492

2722

1.25

5.21

2.5

2.0

21.9

28.4

mg/l

2.06

132

714

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

416

2259

1.27

5.16

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

205

1.95

5.15

1.3

1.1

17.5

20.0

u/l

0.51

136

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

284

1.80

5.13

2.3

2.6

75.8

62.9

mg/l

0.16

(4211845)

200

975

1.42

5.10

3.6

3.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1033

6146

1.17

5.08

1.7

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

218

1080

1.40

5.07

2.0

1.9

3.2

2.2

u/field

0.66

149

765

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

327

1726

1.31

5.05

1.2

1.1

91.1

96.9

3.42

313

1591

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

110

2.32

5.05

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1134

6799

1.16

5.04

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23635

165704

0.94

4.99

5.2

4.7

2.2

2.1

mu/l

0.17

21579

148935

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

101

1098

0.63

4.92

5.8

6.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4720

30580

1.08

4.84

1.5

2.8

2.7

g/l

2.50

2762

17693

(3020491) Glucose [Moles/volume] in Blood

259

1331

1.35

4.83

2.1

1.9

7.5

7.2

mmol/l

0.89

193

910

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.28

4.81

8.4

9.5

—

(3006462) Nitrate [Presence] in Urine

185

900

1.42

4.80

3.6

3.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1675

10343

1.12

4.79

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

281

1.77

4.76

1.4

1.2

76.6

76.4

0.01

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

413

2270

1.26

4.68

1.2

1.1

112.1

117.2

1.95

376

2023

(4146454)

442

2449

1.25

4.67

3.0

2.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

25552

173974

1.06

4.60

8.4

6.1

43.5

40.1

mmol/mol

307.65

23970

158646

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

199

994

1.38

4.47

1.1

47.0

23.4

u/l

1.75

150

751

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.33

4.42

1.3

0.1

g/l

0.25

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2774

20717

0.92

4.37

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

279

1.73

4.35

1.4

1.3

20.1

27.2

1.11

216

(3034274) Bile acid [Moles/volume] in Serum --fasting

146

694

1.45

4.33

1.2

1.4

7.2

15.2

umol/l

3.43

490

(3000475) Leukocytes [#/volume] in Synovial fluid

858

5102

1.16

4.32

1.6

16714.4

14792.4

e6/l

0.54

620

3682

(3006270) Folate [Moles/volume] in Blood

306

1639

1.29

4.31

1.2

321.4

343.1

nmol/l

0.95

226

1328

(3047189) Immunofixation for 24 hour Urine

204

1030

1.37

4.31

1.7

1.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

198

995

1.38

4.31

1.1

119.3

82.3

u/l

2.24

156

781

(3026692) Albumin [Mass/volume] in Peritoneal fluid

121

555

1.51

4.28

1.3

1.4

16.4

12.6

g/l

4.87

417

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

842

0.61

4.26

12.1

16.8

1475.6

1433.7

nmol/l

0.23

808

(3000034) Microalbumin [Mass/volume] in Urine

345

1879

1.27

4.26

3.3

3.0

75.9

46.2

mg/l

0.76

249

1357

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

149

1453

0.71

4.23

4.1

5.3

44.2

116.0

u/ml

2.90

426

(3014271) Vancomycin [Susceptibility]

238

1238

1.33

4.16

3.2

3.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

610

3538

1.19

4.16

3.2

3.5

1.5

0.05

482

2722

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1053

6379

1.14

4.12

1.2

0.9

u/ml

0.03

102

568

(3016018) Differential panel - Cerebral spinal fluid

218

1992

0.75

4.08

1.3

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

141

675

1.44

4.06

1.8

18742.0

11257.1

e6/l

0.63

371

(3042111) Morphology [Interpretation] in Bone marrow Narrative

613

3567

1.19

4.04

1.5

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

449

2537

1.22

4.03

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

745

1.42

4.03

1.2

1.5

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.36

4.01

1.1

1.2

5935.1

2616.9

ng/l

0.57

(3051387) C reactive protein [Mass/volume] in Capillary blood

713

4207

1.17

3.99

4.3

3.4

29.0

28.2

mg/l

0.23

478

2663

(3043410) Blood group antigens tested for on Red Blood Cells

112

514

1.51

3.99

1.5

2.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

432

2436

1.23

3.96

1.1

1.6

1.5

g/l

4.60

388

2199

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

844

6696

0.87

3.95

1.4

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

272

1.70

3.94

5.0

4.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

265

2345

0.78

3.90

1.5

1.8

—

(3033799) Differential panel - Peritoneal fluid

140

675

1.43

3.90

1.8

2.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

449

2549

1.22

3.87

1.3

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

417

2351

1.23

3.84

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

124

1225

0.70

3.83

1.6

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

443

2514

1.22

3.83

1.3

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

415

1.55

3.78

1.2

1.1

78.4

84.6

0.92

209

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

134

645

1.44

3.78

1.3

191.6

314.6

ug/l

0.60

345

(3017732) Neutrophils [#/volume] in Blood

1695

12859

0.90

3.77

3.3

3.0

4.6

4.1

e9/l

8.69

1222

9433

(3005988) Vibrio sp identified in Specimen by Organism specific culture

443

2520

1.22

3.75

1.3

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

483

2771

1.21

3.75

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

104

1055

0.68

3.73

1.2

1.4

0.2

nmol/l

0.17

734

(3025468) Yersinia sp identified in Specimen by Organism specific culture

442

2516

1.22

3.72

1.3

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

144

705

1.41

3.71

1.6

38.7

7.7

nmol/l

0.42

123

598

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

220

1.76

3.71

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

418

1.54

3.68

1.2

1.1

91.8

103.3

1.62

386

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

408

1.54

3.64

1.2

71.1

85.2

2.20

210

(3008898) HLA-B27 [Presence]

506

4149

0.84

3.63

1.1

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

456

2612

1.21

3.62

1.3

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

133

646

1.42

3.60

1.1

1.6

17.5

u/ml

1.55

(3023323) Follitropin [Units/volume] in Serum or Plasma

351

2977

0.81

3.60

1.3

30.6

34.4

iu/l

1.25

296

2519

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

201

1046

1.33

3.57

1.6

1.5

8.2

5.7

u/l

1.46

174

870

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

204

1064

1.33

3.57

1.1

—

(3012898) Urea [Moles/volume] in Urine

193

1.79

3.53

1.5

1.3

133.4

168.0

mmol/l

1.54

165

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

204

1066

1.32

3.53

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

844

5097

1.15

3.52

1.6

7.1

2.8

iu/ml

0.33

208

1149

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

725

0.63

3.50

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

487

2819

1.20

3.47

1.2

1.1

—

(44806420)

128

622

1.42

3.47

2.3

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

206

1847

0.77

3.42

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

242

0.37

3.39

1.5

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

154

776

1.37

3.39

1.9

2.0

11260.1

2172.4

e6/l

0.83

110

533

(3043238) Trisomy 21 risk [Likelihood] in Fetus

181

0.34

3.38

1.9

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

213

1898

0.77

3.38

1.5

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

217

1152

1.30

3.37

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

210

0.33

3.36

1.9

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

210

0.33

3.36

1.9

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

207

1849

0.77

3.35

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

360

2032

1.23

3.34

1.2

43.5

59.7

u/ml

0.66

128

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

209

0.33

3.33

1.9

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

209

0.33

3.33

1.9

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

197

1.75

3.32

1.8

1.6

53.1

44.3

umol/l

0.85

197

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

767

6036

0.87

3.26

1.4

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

135

671

1.39

3.25

1.6

1.8

89074.2

25505.8

u/ml

0.32

104

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

541

4362

0.85

3.22

1.8

1.9

193.9

200.8

pmol/l

0.94

512

4118

(3035637) Corticotropin [Mass/volume] in Plasma

393

2251

1.21

3.17

1.5

—

(3034426) Prothrombin time (PT)

109

524

1.44

3.17

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

705

4243

1.15

3.14

1.3

7.7

6.1

u/ml

0.37

114

678

(3005033) Fetal Nuchal fold Thickness US

173

0.36

3.13

1.9

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

174

0.36

3.12

1.9

1.4

—

(3008295) Osmolality of Serum or Plasma

349

1980

1.22

3.11

1.4

1.3

278.2

277.1

mosm/kgh2o

0.36

280

1509

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

697

4196

1.15

3.09

1.3

6.9

5.2

u/ml

0.22

445

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.34

3.01

1.4

142.5

106.7

ug/l

0.30

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

218

0.38

3.01

1.8

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

21119

147817

0.96

2.97

29.2

18.6

14.1

13.8

156.86

20741

144591

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

751

4563

1.14

2.93

1.2

53.0

37.3

u/ml

0.69

251

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

339

0.51

2.93

2.0

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

993

7627

0.90

2.88

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

597

3575

1.16

2.88

1.2

2.0

5.7

u/ml

2.16

260

(3050794) Legionella sp Ab [Presence] in Serum

170

1.75

2.87

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

236

1297

1.26

2.85

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

495

0.60

2.85

1.1

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

604

3624

1.15

2.84

1.2

22.9

10.6

u/ml

0.39

(3027135) IgG subclass 1 [Mass/volume] in Serum

313

1775

1.22

2.84

1.3

1.4

6.8

6.9

g/l

0.03

222

1190

(3014148) Varicella zoster virus Ab [Titer] in Serum

283

1589

1.23

2.83

1.1

—

(4062490)

312

1772

1.22

2.80

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

312

1773

1.22

2.78

1.3

1.4

0.4

g/l

0.50

225

1192

(3028192) IgG subclass 2 [Mass/volume] in Serum

312

1775

1.22

2.76

1.3

1.4

2.8

3.0

g/l

0.89

223

1191

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

268

1.57

2.76

4.8

5.3

46.9

48.0

ug/min

0.06

222

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

285

1608

1.23

2.74

1.6

23.1

25.3

u/ml

0.31

343

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

245

1361

1.24

2.72

1.3

80.6

477.7

titre

4.17

120

(3002331) Protein [Mass/volume] in Peritoneal fluid

101

495

1.41

2.70

1.4

28.3

39.9

g/l

0.45

376

(3010144) Erythrocytes [#/volume] in Synovial fluid

350

2018

1.20

2.70

1.3

1.4

174720.3

126901.8

e6/l

0.50

246

1389

(3032057) Clostridioides difficile [Presence] in Stool

456

1.42

2.66

2.0

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

306

1745

1.21

2.66

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

110

549

1.38

2.66

1.3

1.5

16.9

15.7

pmol/l

0.43

454

(3027008) Opiates [Presence] in Urine

317

2623

0.83

2.64

2.5

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

299

1.52

2.63

1.4

1.2

66.5

397.5

ng/l

0.68

206

(3027944) Amphetamines [Presence] in Urine

310

2569

0.83

2.62

2.6

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

24974

174043

0.96

2.62

5.5

4.1

1.4

1.3

mmol/l

34.10

23177

155917

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

250

1.57

2.61

2.8

3.3

43.5

41.6

umol/l

0.26

215

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.88

2.60

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

231

1283

1.24

2.59

1.0

1.1

293.1

284.9

mg/l

0.85

209

1141

(3028300) Cannabinoids [Presence] in Urine

319

2632

0.83

2.58

2.5

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

176

1545

0.78

2.58

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

152

802

1.31

2.57

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

487

0.62

2.52

1.1

1.0

0.6

0.4

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

236

1997

0.81

2.50

1.1

3.2

1.3

u/ml

0.81

768

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

135

704

1.32

2.49

2.7

3.0

30.7

29.0

umol/l

0.81

538

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

113

1046

0.74

2.48

1.0

1.6

0.4

u/ml

0.45

257

(3044290) Cell count panel - Cerebral spinal fluid

464

3699

0.86

2.47

1.2

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

268

1521

1.22

2.47

2.2

2.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.65

2.47

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

120

616

1.35

2.46

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

516

1.38

2.46

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

463

2759

1.16

2.45

1.1

425.1

4408.1

iu/ml

0.49

547

(3002621) Streptococcal DNAse B [Units/volume] in Serum

163

1.69

2.45

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

102

1.90

2.45

1.4

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

1489

9487

1.09

2.45

1.4

1.3

272.3

264.3

u/ml

0.08

1363

8727

(3020650) Glucose [Presence] in Urine

457

0.62

2.43

1.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

319

2613

0.84

2.40

2.5

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11218

75598

1.04

2.39

2.4

2.2

76.4

79.0

nmol/l

16.82

9862

66524

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.76

2.39

4.0

3.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

401

2369

1.17

2.38

3.6

3.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

172

1497

0.79

2.38

1.1

1.0

2.2

1.6

u/ml

0.30

338

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

526

3173

1.15

2.37

1.2

32.5

47.8

u/ml

1.91

303

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

236

1329

1.23

2.36

1.3

145.3

61.3

titre

0.49

113

(3019420) Tryptase [Mass/volume] in Serum or Plasma

146

777

1.30

2.35

1.4

1.6

13.0

8.7

ug/l

0.78

133

705

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

141

748

1.30

2.33

2.0

2.3

60.9

55.8

umol/l

0.91

602

(3023420) DNA double strand Ab [Units/volume] in Serum

301

1740

1.20

2.32

1.7

1.4

41.4

23.5

iu/ml

0.89

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

134

707

1.31

2.31

3.0

2.1

26.7

326.3

ug/l

1.27

125

670

(3018133) Calcium [Moles/volume] in Urine

220

1.57

2.30

1.4

1.7

2.5

2.7

mmol/l

0.35

191

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

225

1265

1.23

2.30

2.3

1.8

—

(3003129) Base excess in Capillary blood by calculation

111

570

1.35

2.30

1.7

1.8

0.5

0.7

mmol/l

0.24

100

540

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

177

1.64

2.29

1.2

1.1

15.4

19.4

iu/ml

0.23

(3011335) Digoxin [Mass/volume] in Serum or Plasma

188

1.62

2.28

1.9

2.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

126

661

1.32

2.26

1.4

66.4

56.5

2.51

107

570

(3015183) Erythrocyte sedimentation rate

647

0.69

2.26

1.7

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3176

23041

0.95

2.26

3.4

4.2

12.8

26.9

ug/l

4.27

2625

19064

(3014133) Dog dander IgE Ab [Units/volume] in Serum

147

1294

0.78

2.25

1.1

1.0

5.3

3.0

u/ml

0.70

478

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

189

1.61

2.24

1.1

10.2

1.7

umol/24h

0.52

189

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

106

1.82

2.21

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

278

1.49

2.21

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

117

610

1.32

2.20

1.6

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

568

0.68

2.17

1.1

1.0

0.5

0.6

u/ml

—

132

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

744

0.72

2.14

1.0

1.1

6.9

5.5

u/ml

—

110

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

259

1490

1.20

2.13

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

389

0.62

2.10

1.5

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

114

0.36

2.07

2.5

7.7

—

(3022689) Creatine [Moles/volume] in Urine

108

563

1.32

2.06

1.4

1.5

—

(3023410) Appearance of Cerebral spinal fluid

212

1772

0.82

2.05

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

520

0.68

2.05

2.0

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

439

1.37

2.05

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

439

1.37

2.05

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

439

1.37

2.05

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

439

1.37

2.05

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

194

1090

1.23

2.04

1.3

1.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

112

1005

0.77

2.04

4.4

5.6

49.0

4301.4

u/ml

0.69

191

(3019174) dRVVT (LA screen)

125

1.71

2.02

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

119

1058

0.78

2.02

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

194

1092

1.23

2.01

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

194

1092

1.23

2.01

1.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

194

1092

1.23

2.01

1.3

1.9

—

(3016879) Cocaine [Presence] in Urine

306

2470

0.85

2.00

2.5

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

436

1.36

1.98

2.3

2.4

8.1

7.5

mmol/l

0.62

270

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

263

1.47

1.97

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

153

1.62

1.95

1.3

1.2

13.8

16.6

pmol/l

0.26

132

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

474

1.34

1.92

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

171

1.57

1.88

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

215

1772

0.84

1.83

1.0

2.2

3.1

u/ml

0.80

808

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.76

1.81

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

20224

137989

1.03

1.80

4.8

4.2

15.9

13.1

mm/h

93.31

18712

126358

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

187

1558

0.83

1.80

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

218

1791

0.84

1.80

1.1

5.5

3.7

u/ml

0.43

681

(3046861) Legionella sp Ag [Presence] in Urine

114

1.70

1.79

1.2

1.1

—

(3019225) pH of Specimen

2922

21100

0.95

1.79

5.5

4.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

328

1959

1.16

1.79

1.4

1.3

—

36.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

163

0.47

1.79

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

141

1207

0.81

1.78

1.0

1.3

2.8

u/ml

2.26

449

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

416

1.34

1.76

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

115

1.68

1.74

1.1

1.2

0.1

0.2

nmol/l

0.39

(3032743) Legionella sp IgG Ab [Presence] in Serum

142

1.60

1.73

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5142

34354

1.04

1.72

1.3

1.2

1.6

1.9

u/ml

1.07

1272

8570

(3007147) Virus identified in Stool by Electron microscopy

3.45

1.71

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

643

0.74

1.70

1.1

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

753

0.76

1.70

13.3

12.5

0.7

0.6

mmol/l

0.33

688

(3008401) Mugwort IgE Ab [Units/volume] in Serum

208

1704

0.84

1.68

1.1

1.0

1.3

1.0

u/ml

0.15

669

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

180

1028

1.21

1.68

1.4

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4055

26982

1.04

1.66

1.3

1.2

15.6

14.1

u/ml

0.49

1406

9593

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

180

1029

1.21

1.66

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

547

1.29

1.65

1.1

—

(3036603) Volume of Urine

234

1372

1.18

1.64

1.6

1738.5

1936.0

1.12

340

(3000285) Sodium [Moles/volume] in Blood

274

1.41

1.64

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

198

1624

0.84

1.63

1.9

2.1

47.3

37.3

2.23

195

(3009871) Measles virus Ab [Titer] in Serum

500

1.30

1.63

1.4

1.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

145

1.57

1.61

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12356

83816

1.03

1.60

4.7

5.0

3.2

3.4

ug/l

0.29

10924

75513

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.99

1.57

1.0

1.1

—

(40768441) Liver Pathology biopsy report

170

1407

0.83

1.57

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

401

1.33

1.56

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

330

1.36

1.55

1.1

—

(3024263) Appearance of Synovial fluid

191

1107

1.19

1.55

1.5

1.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

1.55

0.0

5.7

—

0.3

—

(21494434) Karyotype in Bone marrow

311

1875

1.15

1.54

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

250

0.61

1.53

1.5

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.95

1.50

1.2

1.1

—

mmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

110

1.63

1.49

1.5

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

183

1.47

1.45

1.3

1.4

—

490.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1016

6537

1.07

1.44

1.1

14.7

8.8

u/ml

0.18

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.83

1.43

1.1

250.3

277.9

nmol/l

0.32

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

185

0.56

1.43

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

178

1035

1.19

1.42

3.7

3.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

213

1.43

1.40

1.2

79.4

113.1

ug/l

1.59

128

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

551

0.75

1.39

2.3

2.5

123.9

147.6

nmol/l

1.27

474

(3023511) Choriogonadotropin [Units/volume] in Urine

337

1.33

1.39

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

507

1.27

1.38

1.2

1.3

0.3

g/l

1.05

411

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4328

28959

1.04

1.36

1.3

47.5

40.4

iu/ml

1.17

1278

9039

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

515

1.26

1.35

1.4

1.3

28.9

37.4

1.49

336

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

192

1.44

1.34

2.1

2.3

63.6

59.0

0.31

116

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

363

1.31

1.34

2.3

3.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.73

1.34

1.2

1.1

264.9

481.3

u/l

0.69

(3020618) Glucose [Moles/volume] in Synovial fluid

1.73

1.34

1.1

1.0

6.7

5.2

mmol/l

0.86

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

217

1731

0.86

1.33

1.1

60.9

80.8

au/ml

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.89

1.31

1.0

1.1

0.2

0.0

g/l

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.62

1.31

2.4

1.3

25.6

23.1

mmol/l

1.03

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

602

4523

0.92

1.30

1.3

573.8

571.4

mg/l

0.02

572

4299

(3007463) Buprenorphine [Presence] in Urine

2.59

1.29

4.0

7.9

—

(3044941) Cell count panel - Synovial fluid

519

3265

1.10

1.29

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

137

1.51

1.29

2.8

5.5

—

(3000494) Fungus identified in Specimen by Culture

3401

22685

1.04

1.28

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.05

1.26

4.3

3.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

324

1991

1.12

1.26

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

576

1.23

1.25

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

138

1.50

1.25

1.2

1.1

11.0

11.1

u/l

0.01

138

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

155

1.47

1.25

1.8

2.3

15.2

17.4

0.16

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

640

4785

0.92

1.25

2.6

3.4

1141.5

661.5

u/ml

0.51

576

4344

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

435

1.27

1.24

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

268

0.67

1.22

7.8

7.6

1.5

0.3

umol/l

0.63

244

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

102

572

1.23

1.22

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

373

0.72

1.22

2.5

5.3

35.1

54.0

u/l

1.44

141

(40758292) HTLV I+II Ab panel - Serum

300

0.69

1.21

1.1

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

7011

47369

1.03

1.19

4.4

3.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

148

0.56

1.19

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

353

1.29

1.18

1.7

1.5

—

(36660697) Celiac disease serology panel - Serum

1908

12605

1.05

1.16

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

147

1.46

1.14

1.4

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

147

1.46

1.14

1.4

1.8

1.2

0.8

0.31

122

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

26610

182690

1.03

1.14

24.7

15.2

26.1

25.8

mg/l

0.54

23356

146328

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

745

0.81

1.11

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1248

9078

0.95

1.11

1.1

1.2

130.1

134.8

iu/ml

0.14

419

3208

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

320

1.29

1.11

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

802

5178

1.07

1.10

1.6

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

418

2628

1.10

1.6

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

189

1.39

1.10

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

591

0.79

1.10

1.0

0.5

1.0

u/ml

0.97

171

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

468

1.24

1.09

2.2

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

148

872

1.17

1.08

1.4

2.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

193

1524

0.87

1.08

1.0

40.2

42.3

ng/l

0.34

124

1048

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

148

873

1.17

1.07

1.4

2.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

259

2005

0.89

1.07

2.7

2.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

103

0.54

1.06

2.1

1.8

1.6

1.4

umol/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

104

0.53

1.06

1.0

1.2

1.4

—

104

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

193

1521

0.87

1.06

1.0

704.0

725.2

ng/l

0.27

121

1020

(3036670) Protein [Mass/volume] in Synovial fluid

117

678

1.19

1.05

1.1

1.3

41.1

40.4

g/l

0.17

361

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

149

882

1.17

1.04

1.2

1.1

ratio

1.29

304

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

1.04

10.0

8.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

150

0.60

1.03

1.1

0.0

0.7

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

149

883

1.17

1.03

1.4

2.1

—

(40765096) Chromosome analysis panel by Banding

639

0.81

1.03

1.1

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.10

1.03

1.1

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

193

1515

0.88

1.01

1.0

292.4

325.9

ng/l

1.02

128

1058

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

163

1.40

1.01

1.3

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

351

2200

1.10

1.01

3.0

3.4

64.6

58.4

5.72

229

1407

(3022475) Manganese [Moles/volume] in Blood

0.51

1.00

2.0

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

750

0.83

1.00

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

369

1.25

0.99

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

129

1.44

0.98

1.1

1.2

—

(3022145) Colonoscopy Study observation

3109

22102

0.97

0.98

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

189

0.66

0.97

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

173

1043

1.15

0.97

1.7

1.9

2239.0

1190.2

u/l

0.20

327

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.50

0.96

1.5

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

221

0.69

0.95

1.0

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

483

1.21

0.95

1.2

113.2

113.1

0.02

429

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

101

0.55

0.95

7.8

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

102

0.54

0.95

3.9

2.9

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

225

1383

1.12

0.94

3.3

3.7

125.0

149.3

nmol/l

0.61

225

1360

(3021387) Prolactin [Units/volume] in Serum or Plasma

409

3069

0.92

0.94

1.6

1.8

289.6

296.8

mu/l

0.13

375

2849

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

298

1.27

0.94

1.4

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

119

1.45

0.94

1.1

1.2

—

(4015189)

107

624

1.18

0.92

2.4

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

147

880

1.15

0.92

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

137

1.41

0.92

1.4

1.5

52.4

41.0

0.72

(21491868) Cryoglobulin [Mass/volume] in Serum

111

650

1.18

0.92

1.2

0.0

0.7

g/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

119

0.58

0.91

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

126

1009

0.86

0.90

1.6

5.1

5.7

mmol/24h

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

430

0.79

0.90

2.2

1.8

7.5

8.8

mg/l

1.03

343

(44816559) Phosphatidylethanol [Mass/volume] in Blood

455

2905

1.08

0.90

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.56

0.89

1.0

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

530

3926

0.93

0.89

1.4

493.9

1994.3

e6/l

1.95

458

3185

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

710

0.84

0.89

1.4

1.5

28.3

29.3

umol/l

0.43

685

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

273

0.73

0.88

2.3

2.2

2.4

8.8

ug/l

1.12

132

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

414

2637

1.08

0.87

1.5

66.0

59.1

3.25

279

1660

(3001729) Color of Synovial fluid

174

1.35

0.87

1.4

1.7

—

(3045424) Erythrocytes [Presence] in Urine

451

3357

0.93

0.87

1.7

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

552

1.19

0.87

1.4

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

295

0.75

0.86

1.1

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

316

1992

1.10

0.85

1.5

22.4

29.4

3.34

207

1236

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.97

0.84

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

531

3921

0.93

0.84

1.3

1.4

14.5

33.4

e6/l

2.01

439

3008

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

101

814

0.86

0.81

1.1

1.2

1.1

u/l

0.54

419

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.00

0.80

0.0

1.0

—

0.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.80

0.0

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.80

0.0

1.6

—

13.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

281

1.25

0.79

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

234

1462

1.11

0.78

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

502

1.18

0.77

1.5

1.6

10.0

9.3

ug/l

0.65

502

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

226

1410

1.11

0.77

1.2

12.1

5.0

u/ml

0.30

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.48

0.77

1.0

157.6

170.3

pmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

221

1.28

0.76

5.0

2.8

1.4

1.1

mg/l

0.73

163

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

593

0.84

0.76

1.7

3.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.16

0.76

1.2

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

161

1.33

0.75

1.3

0.8

1.1

ml/s/173m2

0.41

105

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

153

0.68

0.74

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.63

0.73

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

109

653

1.15

0.72

1.1

94.6

100.0

1.01

516

(3024869) Neuronal Ab [Presence] in Serum

415

0.81

0.71

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

286

1.23

0.70

1.5

1.6

71.1

51.6

pmol/l

0.48

235

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.73

0.70

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

604

3939

1.06

0.70

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

180

1118

1.11

0.69

1.5

1.3

1.7

1.4

u/ml

0.15

103

590

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

382

2455

1.07

0.69

3.1

3.4

7.8

9.1

nmol/l

0.21

368

2392

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

109

0.63

0.68

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

161

995

1.12

0.68

1.4

1.3

1.5

g/l

0.08

(3002719) Hemoglobin [Mass/volume] in Urine

1.67

0.68

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2777

19636

0.97

0.67

1.8

1.7

1.5

8.23

2311

16877

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

200

1253

1.10

0.66

1.9

2.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

220

1.26

0.66

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

220

1.26

0.66

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

220

1.26

0.66

1.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

180

1373

0.90

0.66

1.8

2.5

510.3

687.7

e6/l

1.16

562

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.56

0.65

1.5

1.3

332.0

535.8

nmol/l

1.02

(3027570) Oxalate [Moles/time] in 24 hour Urine

116

0.65

1.5

1.3

259.1

354.7

umol/24h

1.61

116

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

543

3964

0.94

0.65

1.2

1.3

4.2

3.8

mmol/l

7.31

513

3724

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.64

0.65

1.1

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

593

3877

1.06

0.65

1.5

1.7

38.7

7.1

iu/l

0.70

181

1229

(3029075) Extractable nuclear Ab panel - Serum

467

1.17

0.65

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

240

1.24

0.63

2.3

2.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

780

0.88

0.63

1.9

2.0

—

(3021788) Differential panel - Synovial fluid

594

3887

1.06

0.63

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

494

1.16

0.63

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

779

0.88

0.63

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.62

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.62

0.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

186

1410

0.91

0.62

1.2

1.3

2.3

2.2

mmol/l

0.21

169

1311

(3011288) Drugs identified in Urine by Screen method

219

1647

0.92

0.61

3.8

2.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

662

4796

0.95

0.61

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

339

0.81

0.61

1.6

30.0

56.5

au/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

201

0.76

0.60

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

232

0.77

0.60

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.60

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

286

1.21

0.60

1.9

2.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

405

2627

1.06

0.59

4.4

4.8

340.5

353.5

umol/l

1.12

348

2223

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

236

1.23

0.59

2.3

2.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.60

0.59

1.0

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

234

1488

1.09

0.59

1.2

53.6

39.2

u/ml

0.43

113

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

121

0.68

0.59

1.0

1.1

13.0

15.2

nmol/l

—

(3026470) Cobalt [Mass/volume] in Blood

200

1506

0.92

0.59

1.9

2.0

5.2

3.6

ug/l

0.89

173

1316

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

141

875

1.11

0.58

1.2

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.73

0.58

1.2

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

233

1483

1.08

0.58

1.2

85.3

82.7

u/ml

—

(46235168) Fasting glucose [Moles/volume] in Blood

214

0.77

0.56

2.1

2.5

8.2

7.2

mmol/l

1.18

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

254

1889

0.93

0.56

1.4

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.65

0.56

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.55

0.56

1.1

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.55

0.56

1.1

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

145

1.29

0.56

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

16818

116779

0.99

0.55

3.7

3.2

66.2

54.5

u/l

27.60

15487

107225

(40768443) Skin Pathology biopsy report

1254

8937

0.97

0.55

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

111

0.68

0.55

1.2

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

119

0.70

0.55

3.0

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

2821

19065

1.02

0.55

2.1

2.2

185.3

152.1

ug/g

3.46

2251

14798

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

277

1.20

0.54

1.3

39.0

50.5

0.90

122

(3038026) Centromere Ab [Units/volume] in Serum

239

1530

1.08

0.53

1.2

61.8

47.5

u/ml

0.23

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

265

0.81

0.53

2.4

3.3

52.2

130.5

ng/l

1.70

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

170

1073

1.09

0.53

1.0

1.1

4.7

6.7

nmol/l

0.34

221

(40761536) Microorganisms panel - Urine sediment

2348

15846

1.02

0.52

5.1

4.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.38

0.52

1.6

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.38

0.52

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

247

1.20

0.51

1.1

1.3

6.2

6.7

mmol/l

0.23

117

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

101

621

1.12

0.51

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

261

1680

1.07

0.51

1.9

5.2

3.9

mg/l

3.18

243

1602

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.45

0.50

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

342

2224

1.06

0.50

1.3

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

117

1.30

0.50

1.4

1.5

12.5

13.0

0.05

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.34

0.49

1.0

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

409

1.15

0.49

6.0

5.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

323

2099

1.06

0.48

1.9

2.3

13.4

6.1

titre

—

(3028433) Virus identified in Specimen by Culture

108

670

1.11

0.48

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

528

0.88

0.47

1.3

1.2

120.8

134.6

nmol/l

0.38

379

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.46

0.47

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

130

0.74

0.46

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

568

1.12

0.46

1.7

2.1

11.6

10.5

0.23

512

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

601

1.11

0.45

1.1

1772.7

1550.9

miu/ml

1.02

601

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

175

1.22

0.45

1.2

10.7

9.9

mmol/l

0.45

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

176

0.78

0.45

1.1

1.0

101.8

89.2

ug/l

0.34

127

(3004446) Plasmodium sp identified in Blood by Light microscopy

137

0.76

0.44

2.3

2.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

221

0.81

0.44

1.9

2.0

13.5

17.8

umol/l

1.79

221

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

129

0.75

0.44

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.45

0.43

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

577

1.11

0.43

1.6

2.0

29.9

30.5

0.13

536

(3035933) Granulocytes/100 leukocytes in Blood

354

0.86

0.43

2.9

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

835

5575

1.03

0.42

1.5

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

266

1.17

0.42

3.0

2.7

0.4

0.5

u/field

0.40

266

(3009214) Lutropin [Units/volume] in Serum or Plasma

497

3579

0.96

0.42

1.3

1.4

10.5

9.5

u/l

0.78

396

2880

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

325

2126

1.06

0.42

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.42

0.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

252

1846

0.94

0.41

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

0.72

0.40

1.2

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

139

884

1.09

0.40

1.1

12.9

10.1

iu/ml

0.41

191

(3042517) Benzodiazepines panel - Urine

1.34

0.40

6.1

2.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.41

0.40

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

649

4642

0.96

0.40

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

457

1.12

0.39

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

122

1.24

0.39

1.0

1.2

41.8

44.8

mg/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1126

7975

0.97

0.38

2.8

3.5

1553.3

1216.7

u/ml

0.18

925

6876

(3045142) Bone marrow Pathology biopsy report

341

2470

0.95

0.38

1.3

—

(3025577) Chromium [Mass/volume] in Blood

198

1457

0.94

0.38

1.9

2.1

2.9

2.3

ug/l

0.71

166

1209

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

353

1.13

0.38

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

243

1.16

0.38

1.6

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

156

0.80

0.38

1.2

2.0

—

(4133840)

491

1.11

0.37

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.38

0.37

1.0

0.0

0.1

u/ml

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.38

0.37

1.2

1.1

0.2

1.0

umol/24h

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.38

0.37

1.5

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

125

0.77

0.37

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

123

1.23

0.36

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

385

0.88

0.36

2.9

2.7

1909.4

1751.8

u/l

0.04

341

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19631

134955

1.01

0.36

4.2

3.9

15.1

15.0

pmol/l

3.65

17799

120433

(3007919) Fasciola sp Ab [Titer] in Serum

1.43

0.36

1.2

1.1

—

(3016228) CD19 cells/100 cells in Blood

106

796

0.92

0.35

2.0

6.1

8.3

2.05

778

(3030313) Adrenal Ab [Titer] in Serum

1.31

0.35

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1206

1.06

0.35

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.32

0.34

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1207

1.06

0.34

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

159

1172

0.94

0.34

1.3

34.4

32.0

u/l

0.35

131

942

(3012989) Citrate [Moles/time] in 24 hour Urine

1.34

0.34

1.3

1.7

2.3

mmol/24h

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

1.34

0.34

1.5

1.7

81.5

250.4

nmol/l

—

(3010503) CD19 cells [#/volume] in Blood

164

1207

0.94

0.34

1.9

2.5

0.1

0.4

e9/l

2.71

155

1171

(40759836) Histone Ab [Presence] in Serum by Immunoblot

185

1201

1.06

0.34

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1208

1.06

0.33

1.2

1.1

—

(44813793)

164

1061

1.07

0.33

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

181

1175

1.06

0.33

3.4

2.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1673

11764

0.98

0.33

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

208

1.16

0.33

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

247

1.15

0.33

1.4

2.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1203

1.06

0.32

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1203

1.06

0.32

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

439

0.90

0.32

2.0

2.3

3.2

3.6

ug/l

0.60

156

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

536

1.09

0.32

1.8

1.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

138

1.20

0.32

2.1

3.0

18.6

54.4

pmol/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.31

0.31

1.1

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

110

703

1.08

0.31

1.3

1.5

16.4

24.9

umol/l

3.42

103

665

(3034891) Synovial lining cells/100 cells in Synovial fluid

135

997

0.93

0.31

1.4

1.5

2.7

3.8

0.78

226

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

379

1.11

0.31

1.2

—

(4198724)

412

1.11

0.31

1.9

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

211

0.85

0.31

1.8

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

211

0.85

0.31

5.5

5.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

304

2191

0.96

0.31

1.1

19.7

12.2

au/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

545

1.09

0.30

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

106

0.78

0.30

1.9

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

157

1151

0.94

0.30

1.1

43.9

47.0

mg/l

0.42

133

973

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.27

0.30

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

313

2071

1.04

0.30

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

387

1.11

0.29

1.1

1.2

15.7

16.5

umol/l

0.69

349

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

217

1.14

0.29

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

620

4157

1.03

0.29

1.3

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

140

1.18

0.28

1.2

1.3

—

(3007733) Chloride [Moles/volume] in Urine

1.31

0.28

1.1

90.0

83.4

mmol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

355

0.89

0.28

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

218

1.14

0.28

12.9

9.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

150

1097

0.94

0.27

1.1

320.4

321.9

mg/l

0.02

130

972

(3011325) HIV 1+2 Ab [Presence] in Serum

1.25

0.27

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

127

0.81

0.27

5.5

4.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

164

0.84

0.27

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.23

0.27

1.0

0.4

0.2

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

373

2484

1.04

0.27

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

107

689

1.07

0.27

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

168

1099

1.06

0.26

2.2

2.8

38.0

37.5

0.11

344

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

396

0.91

0.26

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

276

1829

1.04

0.26

1.1

2.6

2.0

iu/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

148

1.17

0.26

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

259

1715

1.04

0.25

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

431

1.09

0.25

1.2

2.2

—

(40758358) Immune stain study

1.24

0.25

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.24

0.25

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.19

0.25

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

458

0.92

0.24

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.33

0.23

3.6

2.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.33

0.23

2.0

2.5

1.4

mu/l

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

400

0.91

0.23

3.1

3.0

6.1

7.4

mg/l

1.06

320

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

183

0.87

0.23

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

301

1.10

0.23

1.0

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.77

0.23

1.1

1.2

1.4

2.0

mg/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

327

0.91

0.22

1.3

1.7

2.8

2.5

ug/l

0.14

187

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

124

810

1.06

0.22

1.1

1.2

63.3

61.4

0.06

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

106

776

0.94

0.22

1.1

877.4

642.0

ng/l

0.16

194

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

300

2001

1.03

0.22

1.2

7.9

7.6

mmol/l

0.85

214

1438

(3016244) Insulin [Units/volume] in Serum or Plasma

107

696

1.06

0.22

2.3

3.1

23.3

24.9

mu/l

0.14

651

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

495

1.07

0.22

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.22

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.22

0.0

1.3

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.22

0.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.19

0.21

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.80

0.21

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

496

1.07

0.21

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

0.7

1.4

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

1.5

2.1

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

1.1

2.0

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

0.4

1.5

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

2.8

1.9

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

0.5

1.0

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

2.8

2.5

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.21

0.21

1.6

0.9

1.5

mg/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

203

0.88

0.21

2.5

2.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

639

0.94

0.21

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.25

0.20

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

489

0.93

0.20

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

100

0.83

0.20

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.19

0.20

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

160

1057

1.04

0.20

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

632

1.06

0.20

1.3

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

117

767

1.05

0.19

1.2

6.1

mmol/l

0.09

101

728

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

107

0.84

0.19

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

245

0.90

0.19

1.6

2.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.83

0.19

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

366

0.92

0.18

2.6

2.4

83.5

174.4

au/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

501

0.94

0.18

1.8

1.6

0.4

ug/l

0.34

318

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

299

1.08

0.18

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

186

1332

0.96

0.18

1.8

2.0

14.8

15.4

0.20

520

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

507

1.06

0.18

1.2

351.4

271.3

pmol/l

0.41

362

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.15

0.17

1.0

1.1

2.4

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

1068

1.04

0.17

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

443

0.93

0.17

1.2

132.0

56.9

mu/l

1.54

317

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

155

1113

0.96

0.17

1.7

1.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.75

0.17

1.8

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.18

0.17

1.6

0.6

1.7

mg/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.17

0.17

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

127

0.87

0.16

1.1

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9667

66959

0.99

0.16

4.3

23.0

21.7

11.64

4638

33273

(4024509)

282

2000

0.97

0.16

1.7

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

1016

1.04

0.16

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

102

1.15

0.16

1.4

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

188

1.10

0.16

1.3

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

270

0.92

0.15

1.3

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.15

0.15

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

119

0.87

0.15

1.1

0.2

0.5

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

588

3998

1.02

0.12

1.1

15.2

8.3

u/ml

0.49

383

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

131

0.90

0.12

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

181

0.91

0.12

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.17

0.12

1.1

0.0

0.1

mg/l

0.46

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

160

1136

0.97

0.12

1.6

2.6

0.2

e9/l

0.92

137

1003

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

259

1.07

0.11

1.2

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

0.91

0.11

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

300

1.06

0.11

1.2

—

(4212803)

215

0.93

0.10

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

260

1.06

0.10

1.2

1.3

96.4

98.8

0.21

255

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

176

1185

1.03

0.10

1.6

2.5

454.2

557.3

e6/l

1.49

138

1011

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

158

0.92

0.10

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

620

1.04

0.10

1.5

1.4

1754611.4

1809846.3

iu/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

292

0.95

0.10

1.1

—

(3027874) Urate [Moles/volume] in Urine

1.13

0.09

1.0

1.1

1.7

1.8

mmol/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

453

0.96

0.09

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.89

0.09

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

1031

1.02

0.09

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

493

1.04

0.08

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

107

1.10

0.08

1.0

1.1

0.0

0.9

u/ml

0.52

(3001556) Androgen free Index in Serum or Plasma

0.80

0.08

1.0

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

283

0.95

0.08

1.1

1.0

0.7

0.9

u/ml

0.17

136

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

346

0.96

0.08

1.0

1.1

—

(3013762) Body weight Measured

0.83

0.07

1.1

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.13

0.07

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

118

797

1.02

0.06

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.90

0.06

1.0

0.0

0.2

u/ml

—

(3024316) Viscosity of Plasma

102

1.08

0.06

1.3

2.2

1.5

1.9

mpas

2.70

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

231

1.05

0.06

1.2

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

109

1.08

0.05

1.1

37.4

114.6

u/l

0.63

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

231

0.96

0.05

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

149

1044

0.98

0.05

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

239

1.04

0.05

1.3

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

111

0.93

0.04

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

252

1757

0.99

0.04

1.8

2.4

1.0

1.1

e9/l

0.47

153

1060

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

144

1.05

0.04

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

167

1166

0.99

0.04

1.5

2.0

15.6

16.0

nmol/l

0.26

151

1079

(3020961) Endomysium IgA Ab [Titer] in Serum

986

6783

1.00

0.03

1.1

247.3

209.4

titre

0.15

172

(3000060) B lymphocytes [#/volume] in Blood

394

0.98

0.02

1.6

1.9

473.0

1657.3

e6/l

0.81

205

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

137

936

1.01

0.02

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

435

0.98

0.02

1.0

1.2

1.6

2.8

umol/l

8.37

399

(4027681)

120

820

1.01

0.02

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

263

1.02

0.02

2.8

2.5

75.7

74.7

pmol/l

0.02

236

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.08

0.02

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

359

2486

1.00

0.01

1.2

178.7

197.6

miu/ml

0.25

878

(1175426) CD3 cells/100 lymphocytes in Blood

195

1353

0.99

0.01

1.8

2.0

72.8

71.4

0.70

178

1293

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

115

800

0.99

0.01

1.1

—

(3048879) Bone marrow aspiration report

100

696

0.99

0.01

1.3

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

657

1.01

0.01

2.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

403

2786

1.00

0.00

2.3

2.6

807.6

1097.1

u/ml

0.19

396

2746

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

500

1.01

0.00

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

308

1.01

0.00

1.0

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.99

0.00

1.0

52.6

35.0

u/ml

—

(44806071)

210

0.99

0.00

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

222

0.99

0.00

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.03

0.00

1.5

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

541

0.99

0.00

1.1

1.3

19.5

22.4

0.12

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.99

0.00

1.5

1.6

—

(3013466) aPTT in Blood by Coagulation assay

0.97

0.00

1.1

40.0

37.3

0.27

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.97

0.00

1.0

0.0

0.1

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

176

1.02

0.00

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

234

1.00

0.00

1.2

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.98

0.00

1.8

1.3

0.8

1.0

u/field

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

169

1.02

0.00

1.1

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.00

0.00

1.1

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.91

0.00

1.3

1.4

0.6

0.5

—

(3049242) von Willebrand panel - Platelet poor plasma

0.94

0.00

2.8

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.89

0.00

1.1

1.0

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.86

0.00

1.0

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_CHD_NOREV – Major coronary heart disease event excluding revascularizations

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Major coronary heart disease event excluding revascularizations

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Major coronary heart disease event excluding revascularizations (I9_CHD_NOREV)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints